T E Starzl

Author PubWeight™ 1739.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evolution of liver transplantation. Hepatology 1982 19.54
2 A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet 1984 10.33
3 Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet 1976 8.11
4 The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980 7.40
5 The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet 1967 7.24
6 Fifteen years of clinical liver transplantation. Gastroenterology 1979 7.19
7 Venous bypass in clinical liver transplantation. Ann Surg 1984 7.04
8 Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med 1981 6.95
9 Orthotopic homotransplantation of the human liver. Ann Surg 1968 6.64
10 Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet 1979 6.23
11 Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery 1991 5.92
12 Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988 5.77
13 Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1984 5.74
14 Refinements in the surgical technique of liver transplantation. Semin Liver Dis 1985 5.70
15 Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974 5.53
16 Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery 1968 5.44
17 Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet 1971 5.24
18 Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet 1984 5.16
19 Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery 1988 5.03
20 Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990 5.01
21 Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990 4.90
22 Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet 1984 4.49
23 Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994 4.32
24 A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet 1985 4.29
25 Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc 1987 4.21
26 Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet 1990 4.18
27 Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994 4.16
28 Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 1989 4.12
29 Malignant lymphomas in transplantation patients. Transplant Proc 1969 4.12
30 Role of liver transplantation in cancer therapy. Ann Surg 1985 4.08
31 Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery 1977 4.08
32 Shwartzman reaction after human renal homotransplantation. N Engl J Med 1968 4.05
33 Extended preservation of human liver grafts with UW solution. JAMA 1989 3.99
34 Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation 1977 3.99
35 Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985 3.91
36 The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet 1967 3.86
37 Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991 3.85
38 The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet 1973 3.84
39 Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet 1976 3.74
40 Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc 1987 3.73
41 Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet 1975 3.66
42 Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet 1980 3.64
43 Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation 1995 3.63
44 Hepatic Retransplantation. Transplant Proc 1985 3.62
45 Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991 3.57
46 Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation 1986 3.54
47 Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet 1982 3.49
48 Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg 1970 3.48
49 Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet 1981 3.38
50 The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 1985 3.38
51 Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991 3.34
52 Kidney transplantation under FK 506 immunosuppression. Transplant Proc 1991 3.31
53 Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc 1990 3.29
54 Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron 1987 3.26
55 Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery 1972 3.26
56 The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988 3.24
57 Changes in blood coagulation. Arch Surg 1966 3.22
58 Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery 1990 3.18
59 Renal transplantation in baboons under FK 506. Surgery 1989 3.17
60 Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg 1985 3.17
61 Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol 1985 3.16
62 Liver transplantation before 1 year of age. J Pediatr 1987 3.15
63 In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc 1988 3.15
64 The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 1991 3.14
65 Fungal infections in liver transplant recipients. Transplantation 1985 3.07
66 De novo malignant tumors in organ transplant recipients. Transplant Proc 1971 3.03
67 Experience with 150 liver resections. Ann Surg 1983 3.01
68 A multifactorial system for equitable selection of cadaver kidney recipients. JAMA 1987 3.01
69 Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg 1965 3.00
70 Death after transplantation; an analysis of sixty cases. Am J Med 1967 2.99
71 Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 1992 2.98
72 Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987 2.95
73 Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995 2.95
74 Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971 2.94
75 Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet 1981 2.92
76 Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1984 2.91
77 Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000 2.91
78 Liver transplantation in adults. Hepatology 1982 2.89
79 Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet 1985 2.88
80 Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc 1988 2.87
81 Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986 2.84
82 Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993 2.81
83 Successful liver transplantation from crossmatch-positive donors. Transplant Proc 1981 2.80
84 Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum 1969 2.80
85 The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation 1990 2.79
86 Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988 2.76
87 Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med 1968 2.72
88 Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 1990 2.66
89 Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc 1970 2.63
90 A review of adult and pediatric post-transplant liver pathology. Pathol Annu 1987 2.62
91 Growth-stimulating factor in regenerating canine liver. Lancet 1979 2.61
92 Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transplant Proc 1990 2.60
93 Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation 1990 2.59
94 Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985 2.59
95 Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991 2.59
96 Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery 1968 2.58
97 Pregnancy after liver transplantation under tacrolimus. Transplantation 1997 2.50
98 Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc 1981 2.49
99 Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant 2006 2.48
100 Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg 1978 2.48
101 Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994 2.48
102 Personal experience with 411 hepatic resections. Ann Surg 1988 2.46
103 Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg 1973 2.44
104 Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984 2.44
105 Variable convalescence and therapy after cadaveric renal transplantation under cyclosporin A and steroids. Surg Gynecol Obstet 1982 2.42
106 Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. Transplant Proc 1990 2.40
107 Liver transplantation across ABO blood groups. Surgery 1986 2.39
108 Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery 1970 2.38
109 Prioritization and organ distribution for liver transplantation. JAMA 1994 2.38
110 Toxicology of FK-506 in the Lewis rat. Transplant Proc 1987 2.37
111 The Eck fistula in animals and humans. Curr Probl Surg 1983 2.35
112 Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1994 2.35
113 Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet 1979 2.33
114 The antibody crossmatch in liver transplantation. Surgery 1986 2.33
115 Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg 1983 2.33
116 Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 1970 2.33
117 Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg 1968 2.32
118 The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994 2.32
119 Liver transplantation for type IV glycogen storage disease. N Engl J Med 1991 2.31
120 The effects of FK 506 on renal function after liver transplantation. Transplant Proc 1990 2.31
121 Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998 2.31
122 Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med 1993 2.29
123 Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression. Transplant Proc 1991 2.28
124 Animal research in liver transplantation with special reference to the dog. Semin Liver Dis 1985 2.28
125 The hepatotropic influence of cyclosporine. Surgery 1990 2.27
126 Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc 1991 2.26
127 Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med 1984 2.25
128 Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg 1995 2.25
130 Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet 1968 2.23
131 Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999 2.22
132 Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmacol 1988 2.21
133 Cardiac transplantation with cyclosporin A and prednisone. Ann Surg 1982 2.21
134 Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994 2.20
135 Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993 2.17
136 Left hepatic trisegmentectomy. Surg Gynecol Obstet 1982 2.16
137 Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985 2.16
138 A growth factor in fine vascular anastomoses. Surg Gynecol Obstet 1984 2.15
139 Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc 1990 2.15
140 Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506. Transplantation 1993 2.14
141 Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg 1971 2.14
142 FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation 1990 2.13
143 An everting technique for intraluminal vascular suturing. Surg Gynecol Obstet 1968 2.12
144 Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987 2.11
145 One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc 1991 2.10
146 The side effects of FK 506 in humans. Transplant Proc 1990 2.08
147 Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986 2.07
148 Human renal transplants. I. Glomerular changes. Lab Invest 1967 2.06
149 Progression of neurovisceral storage disease with supranuclear ophthalmoplegia following orthotopic liver transplantation. Pediatrics 1986 2.04
150 Techniques for combined procurement of hearts and kidneys with satisfactory early function of renal allografts. Surg Gynecol Obstet 1983 2.03
151 Coagulation during and after orthotopic transplantation of the human liver. Arch Surg 1969 2.03
152 Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet 1989 2.01
153 Low flow venovenous bypasses in small dogs and pediatric patients undergoing replacement of the liver. Surg Gynecol Obstet 1986 2.00
154 Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. N Engl J Med 1980 2.00
155 Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg 1998 1.99
156 Liver transplantation in hemophilia A. Blood 1987 1.98
157 Biliary Excretion of Cyclosporine in Liver Transplant Patients. Transplant Proc 1985 1.98
158 Liver transplantation against T cell-positive warm crossmatches. Transplant Proc 1984 1.96
159 Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506. Transplantation 1991 1.95
160 FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. Lancet 1990 1.94
161 Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989 1.94
162 Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin. Transplantation 1993 1.94
163 Infections in recipients of liver homografts. N Engl J Med 1968 1.92
164 Liver resection for metastatic colorectal cancer. Surgery 1986 1.92
165 The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet 1975 1.91
166 Urological complications in 216 human recipients of renal transplants. Ann Surg 1970 1.90
167 Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988 1.89
168 Avenues of future research in homotransplantation of the liver with particular reference to hepatic supportive procedures, antilymphocyte serum, and tissue typing. Am J Surg 1966 1.89
169 Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc 1991 1.89
170 Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995 1.88
171 Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis 1985 1.88
172 Orthotopic liver transplantation in children: two-year experience with 47 patients. Pediatrics 1984 1.86
173 Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996 1.86
174 Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med 1973 1.85
175 Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 1992 1.85
176 Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg 1982 1.84
177 Progress in homotransplantation of the liver. Adv Surg 1966 1.83
178 Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995 1.83
179 Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet 1989 1.82
180 Liver transplantation. Johns Hopkins Med J 1978 1.82
181 Orthotopic liver transplantation in the mouse. Transplantation 1991 1.82
182 Biliary Tract Complications in Liver Transplantation Under Cyclosporin-Steroid Therapy. Transplant Proc 1983 1.82
183 Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. J Am Coll Surg 1994 1.81
184 Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997 1.81
185 Fungus infections after liver transplantation. Ann Surg 1977 1.81
186 Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg 1979 1.80
187 Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972 1.80
188 Pathologic observations in human allograft recipients treated with FK 506. Transplant Proc 1990 1.80
189 Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery 1971 1.79
190 Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg 1968 1.78
191 Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991 1.78
192 Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation 1966 1.78
193 The quality of life after liver transplantation. Transplant Proc 1979 1.78
194 Liver regeneration in dogs: morphologic and chemical changes. J Surg Res 1978 1.78
195 Cyclophosphamide and human organ transplantation. Lancet 1971 1.77
196 Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc 1991 1.77
197 Use of FK 506 in pediatric patients. Transplant Proc 1991 1.77
198 Induction of DR/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts. Transplantation 1985 1.75
199 Current status of hepatic transplantation. Semin Liver Dis 1983 1.75
200 Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet 1975 1.74
201 Metabolic effects of hepatic replacement in Wilson's disease. Transplant Proc 1973 1.73
202 Retransplantation of the liver. Semin Liver Dis 1985 1.73
203 Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol 1986 1.73
204 Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 1998 1.72
205 The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988 1.72
206 Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet 1980 1.72
207 Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg 1975 1.72
208 The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg 1996 1.71
209 Homotransplantation of the liver. Transplantation 1967 1.71
210 Transplantation. JAMA 1990 1.71
211 Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991 1.71
212 Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. Transplant Proc 1990 1.71
213 Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology 1994 1.70
214 Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, alpha 1-antitrypsin, C8, and factor B. Clin Immunol Immunopathol 1980 1.69
215 Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest 1968 1.69
216 Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc 1991 1.69
217 Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation 1992 1.68
218 Changes in serum haptoglobin and group specific component after orthotopic liver homotransplantation in humans. Proc Soc Exp Biol Med 1968 1.68
219 Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991 1.68
220 Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement. Transplant Proc 1984 1.66
221 Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg 1966 1.66
222 Portacaval shunt in hyperlipoproteinaemia. Lancet 1973 1.66
223 Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation. With oarticular reference to the liver. Transplantation 1996 1.65
224 Cyclosporine A augments the regenerative response after partial hepatectomy in the rat. Transplant Proc 1988 1.64
225 Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. Am J Pathol 1986 1.63
226 Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995 1.63
227 The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet 1978 1.63
228 Blood use in liver transplantation. Transfusion 1987 1.63
229 Immunosuppression and other nonsurgical factors in the improved results of liver transplantation. Semin Liver Dis 1985 1.62
230 Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990 1.61
231 Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988 1.61
232 Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet 1992 1.61
233 Development of a suprahepatic recipient vena cava cuff for liver transplantation. Surg Gynecol Obstet 1979 1.60
234 The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc 1991 1.60
235 Thoracic duct fistula and renal transplantation. Ann Surg 1979 1.60
236 Orthotopic liver transplantation for Wilson's disease. Lancet 1971 1.60
237 Renal homotransplantation in pediatric patients. Pediatrics 1971 1.59
238 The spectrum of portal vein thrombosis in liver transplantation. Ann Surg 1991 1.58
239 Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989 1.58
240 Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 1.57
241 Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc 1990 1.56
242 The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 1988 1.56
243 Liver transplantation for fulminant hepatic failure. Semin Liver Dis 1985 1.56
244 New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991 1.56
245 FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc 1987 1.56
246 Principles of multiple organ procurement from cadaver donors. Ann Surg 1983 1.56
247 Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet 1993 1.55
248 Mucosal damage and recovery of the intestine after prolonged preservation and transplantation in dogs. Transplantation 2001 1.55
249 Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet 1975 1.55
250 The effect of partial portacaval transposition on the canine liver. Surgery 1967 1.54
251 Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation 1977 1.54
252 Liver and kidney transplantation in children receiving cyclosporin A and steroids. J Pediatr 1982 1.54
253 Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999 1.54
254 Cholangiography and interventional biliary radiology in adult liver transplantation. AJR Am J Roentgenol 1985 1.54
255 Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000 1.53
256 Immunofluorescent examination of biopsies from long-term renal allografts. N Engl J Med 1970 1.53
257 Angiography of liver transplantation patients. Radiology 1985 1.53
258 Liver replacement for alpha1-antitrypsin deficiency. Surgery 1977 1.53
259 Homotransplantation of the liver in a patient with hepatoma and hereditary tyrosinemia. J Pediatr 1978 1.53
260 Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987 1.53
261 Acute and chronic renal failure in liver transplantation. Nephron 1990 1.52
262 Medical aspects of liver transplantation. Hepatology 1984 1.52
263 Split tolerance induced by orthotopic liver transplantation in mice. Transplantation 1994 1.52
264 A trial with heterologous antilymphocyte globulin in man. Transplant Proc 1969 1.51
265 Cyclosporine monitoring in liver transplant patients. Transplantation 1985 1.51
266 Liver replacement for pediatric patients. Pediatrics 1979 1.51
267 Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet 1969 1.51
268 Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995 1.51
269 Sex hormone-related functions in regenerating male rat liver. Gastroenterology 1986 1.51
270 Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg 1976 1.50
271 The effect of FK-506 on hyperacute rejection in presensitized rats. Transplant Proc 1987 1.49
272 FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery 1991 1.49
273 An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant 2001 1.48
274 Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc 1997 1.48
275 Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg 1997 1.47
276 Indications for liver transplantation in the cyclosporine era. Surg Clin North Am 1986 1.46
277 Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol 1989 1.45
278 Hamster to rat kidney xenotransplantation. Effects of FK 506, cyclophosphamide, organ perfusion, and complement inhibition. Transplantation 1995 1.45
279 Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation 1992 1.45
280 Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001 1.44
281 Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res 1987 1.43
282 Intestinal transplantation at the University of Pittsburgh. Transplant Proc 1994 1.42
283 Hepatitis C testing. Comparison of Ortho's EIA and RIBA II tests in 1,182 patients undergoing primary liver transplantation. Am J Clin Pathol 1992 1.42
285 Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997 1.41
286 Liver transplantation in children with biliary atresia and vascular anomalies. J Pediatr Surg 1974 1.41
287 Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients. Transplant Proc 1991 1.41
288 Cryptococcosis after renal transplantation: report of ten cases. Surgery 1976 1.41
289 HLA matching assessed from early graft function. Transplant Proc 1987 1.40
290 Use of a U tube in the treatment of biliary disease. Surg Gynecol Obstet 1976 1.40
291 A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc 1991 1.40
292 Decline in survival after liver transplantation. Arch Surg 1980 1.39
293 Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology 1987 1.39
294 Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. Transplantation 1997 1.39
295 Hepatotrophic substances. Prog Liver Dis 1979 1.39
296 Causes of death after kidney transplantation. JAMA 1983 1.38
297 Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 1990 1.38
298 Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation 1981 1.38
299 The effect of liver disease on the need for venous decompression during the anhepatic phase of canine orthotopic liver transplantation. Surgery 1970 1.38
300 Abdominal multivisceral transplantation. Transplantation 1995 1.37
301 Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. Transplant Proc 1988 1.37
302 Excisional treatment of cavernous hemangioma of the liver. Ann Surg 1980 1.37
303 Liver transplantation. Med Clin North Am 1979 1.36
304 Late function of the orthotopic liver homograft. Surg Forum 1965 1.36
305 Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997 1.36
306 Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997 1.36
307 Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc 1987 1.36
308 FK 506 as a growth control factor. Transplant Proc 1990 1.36
309 Orthotopic Liver Transplantation in Children With Hepatic-Based Metabolic Disease. Transplant Proc 1983 1.36
310 The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992 1.35
311 Clinical heterotransplantation of the liver. Transplant Proc 1970 1.35
312 OKT3 in the reversal of acute hepatic allograft rejection. Transplant Proc 1987 1.35
313 Biopharmaceutical aspects of FK-506. Transplant Proc 1987 1.34
314 The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum 1965 1.34
315 Blood transfusion in liver transplantation. Transfusion 1985 1.34
316 Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis 1991 1.33
317 Virus-induced obstruction of the ureteric and cystic duct in allograft recipients. Transplant Proc 1973 1.33
318 Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 2000 1.33
319 The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet 1975 1.33
320 Major colonic problems in human homotransplant recipients. Arch Surg 1970 1.33
321 Linear growth following pediatric liver transplantation. Am J Dis Child 1987 1.33
322 Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg 1994 1.33
323 Assay of FK 506 in plasma. Transplant Proc 1990 1.32
324 A fresh look at augmenter of liver regeneration in rats. Hepatology 1999 1.32
325 Donor dendritic cell repopulation in recipients after rat-to-mouse bone-marrow transplantation. Lancet 1992 1.32
326 Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet 1970 1.32
327 The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol 1993 1.32
328 Changing concepts: liver replacement for hereditary tyrosinemia and hepatoma. J Pediatr 1985 1.32
329 Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1992 1.32
330 Liver transplantation in a hemophiliac. N Engl J Med 1985 1.32
331 Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol 1990 1.31
332 Human renal transplants. 3. Immunopathologic studies. Lab Invest 1970 1.31
333 Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Hum Immunol 1988 1.31
334 Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 1990 1.31
335 Ex vivo perfusion, arteriography, and autotransplantation procedures for kidney salvage. Surg Gynecol Obstet 1973 1.31
336 Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology 1986 1.31
337 Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995 1.31
338 A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989 1.30
339 Evidence that host size determines liver size: studies in dogs receiving orthotopic liver transplants. Hepatology 1987 1.30
340 Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999 1.30
341 Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc 1990 1.30
342 Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology 1991 1.30
343 Small bowel and liver/small bowel transplantation in children. Semin Pediatr Surg 1993 1.30
344 Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci 1975 1.30
345 Transplantation in HIV+ patients. Transplantation 1990 1.29
346 Improvements in the preparation of heterologous antilymphocyte globulin with special reference to absorption and diethylaminoethyl cellulose batch production. Surgery 1969 1.29
347 Cadaveric renal transplantation under cyclosporine-steroid therapy. Surg Gynecol Obstet 1983 1.29
348 Pediatric Liver Transplantation Under Therapy With Cyclosporin-A and Steroids. Transplant Proc 1983 1.28
349 Successful small bowel allotransplantation in dogs with cyclosporine and prednisone. Transplantation 1984 1.28
350 Endotoxemia and human liver transplantation. Transplant Proc 1989 1.28
351 Current status of intestinal transplantation in children. J Pediatr Surg 1998 1.28
352 The effect of FK 506 and CyA on the Lewis rat renal ischemia model. Transplant Proc 1990 1.28
353 Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. Hepatology 1995 1.27
354 Synthesis of human plasminogen by the liver. Science 1980 1.27
355 Excretion of cyclosporine and its metabolites in human bile. Transplant Proc 1986 1.27
356 Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases. Hepatology 1986 1.27
357 Analysis of liver transplantation. Hepatology 1984 1.26
358 Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. Transplant Proc 1992 1.26
359 Immunosuppression and cancer. Transplant Proc 1973 1.26
360 Hepatic artery thrombosis after liver transplantation: radiologic evaluation. AJR Am J Roentgenol 1986 1.26
361 Liver transplantation of Budd-Chiari syndrome. JAMA 1976 1.26
362 Analysis of surgical complications after 397 hepatic transplantations. Surg Gynecol Obstet 1990 1.25
363 Cholangiographic findings in hepatic artery occlusion after liver transplantation. AJR Am J Roentgenol 1987 1.24
364 The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. Transplantation 1991 1.24
365 Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology 1990 1.24
366 Fungal Infections After Liver Transplantation. Transplant Proc 1988 1.24
367 Infectious complications after small bowel transplantation in adults. Transplant Proc 1994 1.24
368 Role of bile and bile salts on cyclosporine absorption in dogs. Transplant Proc 1987 1.24
369 Epstein-Barr virus, cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987 1.24
370 Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 1992 1.24
371 Parenthood in renal homograft recipients. JAMA 1971 1.24
372 Rapid growth of an intact human liver transplanted into a recipient larger than the donor. Gastroenterology 1987 1.24
373 Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg 1999 1.24
374 Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg 1972 1.24
375 Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc 1991 1.24
376 TIMY--a center-oriented transplant information management system. Transplant Proc 1988 1.23
377 Experience with primary liver transplantation across ABO blood groups. Transplant Proc 1987 1.23
378 Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol 1993 1.23
379 Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). Transplantation 1992 1.23
380 Effects of renal impairment on liver transplantation. Gastroenterology 1987 1.23
381 Hepatic Retransplantation--an analysis of risk factors associated with outcome. Transplantation 1996 1.22
382 Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation 1998 1.22
383 Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation. Cancer 1988 1.22
384 Effects of in vivo treatment with FK506 on natural killer cells in rats. Transplantation 1991 1.22
385 Donor bone marrow cell infusion without recipient cytoablation induces acceptance of rat islet allografts. Transplant Proc 1994 1.22
386 Blood coagulation in uremic patients before and after hemodialysis and transplantation of the kidney. Arch Surg 1966 1.22
387 Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993 1.21
388 Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection. Transplantation 1994 1.21
389 Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 1990 1.21
390 Thoracic duct drainage in organ transplantation: will it permit better immunosuppression? Transplant Proc 1979 1.21
391 Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant 1989 1.20
392 Liver transplantation in older patients. N Engl J Med 1987 1.20
393 Liver transplantation for type I glycogen storage disease. Lancet 1983 1.20
394 Regenerating rat liver: correlations between estrogen receptor localization and deoxyribonucleic acid synthesis. Gastroenterology 1984 1.19
395 Renal transplantation in black recipients at the University of Pittsburgh. Transplant Proc 1989 1.19
396 Childbearing after liver transplantation. Transplantation 1990 1.19
397 Perspectives in organ transplantation. Antibiot Chemother 1969 1.19
398 Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg 1992 1.18
399 Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects. J Clin Invest 1984 1.18
400 Immunosuppression and malignant neoplasms. N Engl J Med 1970 1.18
401 Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts. Hepatology 1992 1.18
402 Tacrolimus in pediatric renal transplantation. Transplantation 1996 1.18
403 Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted? Transplantation 1994 1.18
404 Adenovirus infection in pediatric liver transplant recipients. J Infect Dis 1992 1.18
405 Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993 1.18
406 Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet 1993 1.18
407 Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 1995 1.17
408 Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet 1989 1.17
409 Body temperature changes during organ transplantation. Anesth Analg 1971 1.17
410 Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 1995 1.17
411 A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation 1998 1.16
412 Isolation, phenotype, and allostimulatory activity of mouse liver dendritic cells. Transplantation 1994 1.16
413 The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc 1991 1.16
414 Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994 1.16
415 Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.16
416 A decade followup in early cases of renal homotransplantation. Ann Surg 1974 1.16
417 Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med 1996 1.16
418 Antibody localization in horse, rabbit, and goat antilymphocyte sera. Surgery 1970 1.15
419 Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995 1.15
420 Liver transplantation in cystic fibrosis. Lancet 1989 1.15
421 After 20 years, liver transplantation comes of age. Ann Intern Med 1983 1.14
422 Choosing a pediatric recipient for orthotopic liver transplantation. J Pediatr 1987 1.14
423 Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts. Transpl Int 1988 1.14
424 Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc 1990 1.14
425 Renal failure in children with hepatic failure undergoing liver transplantation. J Pediatr 1986 1.14
426 A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation 1999 1.14
427 Liver transplantation in the ciclosporin era. Prog Allergy 1986 1.14
428 Hepatic resection for cystic lesions of the liver. Ann Surg 1993 1.14
429 Surgical complications in the postoperative period of liver transplantation in children. Transplant Proc 1984 1.13
430 A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996 1.13
431 Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology 1991 1.13
432 Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. Transplantation 1991 1.13
433 Liver transplantation in patients with patent splenorenal shunts. Surgery 1987 1.12
434 Serum complement after orthotopic transplantation of the human liver. Clin Exp Immunol 1972 1.12
435 Indications for pediatric liver transplantation. J Pediatr 1987 1.12
436 Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation 1989 1.12
437 Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992 1.12
438 Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg 1976 1.11
439 Transplantation. JAMA 1989 1.11
440 The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet 1978 1.11
441 Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988 1.11
442 Percutaneous transhepatic cholangiography and biliary drainage after liver transplantation: a five-year experience. Gastrointest Radiol 1987 1.10
443 Tacrolimus in renal transplantation. Transplant Proc 1996 1.10
444 Improved surgical technique for the establishment of a murine model of aortic transplantation. Microsurgery 1998 1.10
445 Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation 1993 1.10
446 T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls. J Clin Immunol 1984 1.10
447 Liver transplantation for malignant tumors. Gastroenterol Clin North Am 1988 1.09
448 Five-Year Survival After Liver Transplantation. Transplant Proc 1985 1.09
449 Liver resection for hepatic adenoma. Arch Surg 1979 1.09
450 Liver transplantation for biliary atresia. World J Surg 1984 1.09
451 Nutritional management of intestinal transplant recipients. Transplant Proc 1993 1.09
452 Attempted spleen transplant in classical hemophilia. Transplantation 1969 1.09
453 Gastrointestinal complications of hepatic transplantation. Transplant Proc 1979 1.09
454 An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders. J Clin Pharmacol 1993 1.09
455 Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997 1.09
456 The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation 1967 1.09
457 Human islet isolation and purification from pediatric-age donors. Transplant Proc 1991 1.09
458 Chronic renal homograft function: correlation with histology and lymphocyte antigen matching. Am J Med 1967 1.08
459 Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. Transplant Proc 1990 1.08
460 Hyperacute rejection of renal homografts: with particular reference to coaglation changes, humoral antibodies, and formed blood elements. Transplant Proc 1971 1.08
461 Improved hepatic function in the 24-hour preserved rat liver with UW-lactobionate solution and SRI 63-441. Gastroenterology 1988 1.08
462 Functional cooperation of xenoproteins after hamster-to-rat liver transplantation: With particular reference to hamster C3 and secretory component for rat IgA. Xenotransplantation 1995 1.08
463 Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995 1.08
464 Progress in liver transplantation. World J Surg 1977 1.07
465 Treatment of upper abdominal malignancies with organ cluster procedures. Clin Transplant 1990 1.07
466 Immunopathological studies of orthotopic human liver allografts. Lancet 1972 1.07
467 Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol 1987 1.07
468 Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl 2000 1.07
469 Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc 1997 1.07
470 Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997 1.07
471 CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1993 1.07
472 Hepatic nitric oxide generation as a putative mechanism for failure of intrahepatic islet cell grafts. Transplant Proc 1992 1.07
473 Liver transplantation under cyclosporine: a decade of experience. Transplant Proc 1991 1.07
474 Cytomegalovirus disease in intestinal transplantation. Transplant Proc 1995 1.07
475 In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation 1995 1.06
476 Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation 1994 1.06
477 Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology 1992 1.06
478 Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol 1972 1.06
479 Adenoviral infections in pediatric liver transplant recipients. JAMA 1987 1.06
480 Proceedings: The outcome of kidney retransplantation. Arch Surg 1974 1.06
481 Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol 1993 1.06
482 Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 1984 1.06
483 Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989 1.06
484 Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci 1994 1.06
485 Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg 1997 1.05
486 Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990 1.05
487 Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses 1998 1.05
488 Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol 1993 1.05
489 FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991 1.05
490 The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc 1991 1.05
491 Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.05
492 Eleven and two-thirds years' survival after canine orthotopic liver transplantation. Transplantation 1977 1.04
493 Purine nucleoside phosphorylase: a new marker for free oxygen radical injury to the endothelial cell. Hepatology 1990 1.04
494 The influence of donor and recipient strains in isolated small bowel transplantation in rats. Transplant Proc 1994 1.04
495 Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc 1973 1.04
496 The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology 1997 1.04
497 Long-term culture of viable human pancreatic islets in pyruvate-rich medium. Transplant Proc 1995 1.04
498 Current status of FK 506 in liver transplantation. Transplant Proc 1991 1.04
499 Use of living donors in kidney transplantation in man. Arch Surg 1970 1.04
500 The UW solution for canine kidney preservation. Its specific effect on renal hemodynamics and microvasculature. Transplantation 1989 1.04
501 Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992 1.04
502 Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation 1999 1.04
503 Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 1990 1.04
504 Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 1985 1.04
505 Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants. J Med Virol 1995 1.03
506 Pediatric liver transplantation. Transplant Proc 1987 1.03
507 Antipyrine kinetics in liver disease and liver transplantation. Clin Pharmacol Ther 1986 1.03
508 Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990 1.03
509 Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplant Proc 1993 1.03
510 Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc 1993 1.03
511 Enteric drainage of pancreas transplants revisited. Transplant Proc 1995 1.03
512 Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. Am J Surg 1995 1.03
513 The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol 1991 1.02
514 Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int 1997 1.02
515 FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol 1993 1.02
516 A clinicopathologic study of primary hepatic carcinoid tumors. Cancer 1990 1.02
517 Histopathology of human renal allograft rejection under FK 506: a comparison with cyclosporine. Transplant Proc 1991 1.02
518 Advantages of venous bypass during orthotopic transplantation of the liver. Semin Liver Dis 1985 1.02
519 Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 1996 1.02
520 Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet 1981 1.01
521 Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am 1988 1.01
522 Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population. Transplant Proc 1991 1.01
523 Major colonic complications of hepatic transplantation. Dis Colon Rectum 1979 1.01
524 FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc 1991 1.01
525 Hepatic regeneration and growth factors. J Surg Oncol Suppl 1993 1.01
526 Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients. Transplant Proc 1992 1.01
527 Further steps of hepatic stimulatory substance purification. Dig Dis Sci 1991 1.01
528 Severe neurological complications following orthotopic liver transplantation in patients receiving FK 506 and prednisone. J Hepatol 1994 1.00
529 Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999 1.00
530 Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation 1992 1.00
531 FK 506 in the management of transplant-related nephrotic syndrome and steroid-resistant nephrotic syndrome. Transplant Proc 1991 1.00
532 Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc 1987 1.00
533 Doppler ultrasound as a screen for hepatic artery thrombosis after liver transplantation. Transplantation 1986 1.00
534 A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology 1997 1.00
535 Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia. Lancet 1974 1.00
536 Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 1996 1.00
537 Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc 1971 1.00
538 Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999 1.00
539 Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. Transplant Proc 1995 1.00
540 Epidermal growth factor and proliferation in rat hepatocytes in primary culture isolated at different times after partial hepatectomy. Cancer Res 1986 1.00
541 Pseudoaneurysms complicating organ transplantation: roles of CT, duplex sonography, and angiography. Radiology 1988 1.00
542 Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. Transplantation 1991 1.00
543 A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. J Thorac Cardiovasc Surg 1993 1.00
544 Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 1996 0.99
545 Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. Rev Infect Dis 1991 0.99
546 Renal Transplantation in the Presence of a Positive Cytotoxic Antibody. Transplant Proc 1988 0.99
547 Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc 1995 0.99
548 The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine. Hepatology 1987 0.99
549 Induction of hepatocyte stimulating activity by T3 and appearance of the activity despite inhibition of DNA synthesis by adriamycin. Horm Metab Res 1984 0.99
550 Liver transplantation--1978. Transplant Proc 1979 0.99
551 FK 506 dosage in human organ transplantation. Transplant Proc 1990 0.99
552 The liver transplant waiting list--a single-center analysis. Transplantation 1991 0.99
553 Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. Transplant Proc 1997 0.98
554 Liver retransplantation in adults: overall results and determinant factors affecting the outcome. Transplant Proc 1991 0.98
555 Liver transplantation for fulminant hepatic failure. Transplant Proc 1989 0.98
556 Hyperacute rejection of a transplanted human heart. Transplantation 1981 0.98
557 The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. Transplantation 1992 0.98
558 Personal experience with the procurement of 132 liver allografts. Transpl Int 1989 0.98
559 Pediatric renal transplantation under FK 506 immunosuppression. Transplant Proc 1991 0.98
560 Neuropsychiatric status after liver transplantation. J Lab Clin Med 1984 0.98
561 Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. Transplantation 1994 0.98
562 The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet 1973 0.98
563 Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis. Gastroenterology 1978 0.98
564 Arterioportal fistula following liver biopsy. Three cases occurring in liver transplant recipients. Dig Dis Sci 1995 0.98
565 A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology 1989 0.98
566 Islet xenografts in fully xenogeneic (rat----mouse) chimeras: evidence for normal regulation of function in a xenogeneic mouse environment. Surgery 1992 0.98
567 Thymectomy and renal homotransplantation. Clin Exp Immunol 1970 0.98
568 Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation 1989 0.98
569 Interspecies reactivity and intraspecies specificity of antilymphoid globulin. Surgery 1967 0.97
570 Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation. Transplant Proc 1988 0.97
571 Cyclosporine and its metabolites in mother and baby. Transplantation 1988 0.97
572 Heterologous antilymphocyte globulin. N Engl J Med 1968 0.97
573 Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation 1989 0.97
574 Composition of human islet cell preparations for transplantation. Acta Diabetol 1992 0.97
575 The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production. Transplantation 1993 0.97
576 Long-term in vivo function of human mantled islets obtained by incomplete pancreatic dissociation and purification. Transplant Proc 1995 0.97
577 Kidney transplantation. Modern trends in kidney transplantation. Transplant Proc 1977 0.97
578 Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation 1994 0.97
579 Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction. Transplant Proc 1995 0.97
580 Budd-Chiari syndrome recurring in a transplanted liver. Gastroenterology 1983 0.97
581 Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc 1971 0.97
582 Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci 1991 0.97
583 Personal experience with orthotopic liver transplantation. Transplant Proc 1972 0.96
584 Gastrointestinal bleeding after liver transplantation. Transplantation 1997 0.96
585 Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991 0.96
586 Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996 0.96
587 Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 1993 0.96
588 Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. Transplant Proc 1992 0.96
589 Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996 0.96
590 The changing face of hepatic resection. Curr Probl Surg 1989 0.96
591 Pediatric lung transplantation. The years 1985 to 1992 and the clinical trial of FK 506. J Thorac Cardiovasc Surg 1993 0.96
592 Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999 0.96
593 Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transpl Int 1994 0.95
594 Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation 2000 0.95
595 The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993 0.95
596 Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol 2001 0.95
597 Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. Transplant Proc 1996 0.95
598 Attenuation of ischemic liver injury by augmentation of endogenous adenosine. Transplantation 1997 0.95
599 The successful use of older donors for liver transplantation. JAMA 1989 0.95
600 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology 1982 0.95
601 Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver resections. Hepatology 1990 0.95
602 Liver transplantation in black recipients: Pittsburgh. Transplant Proc 1989 0.95
603 Successful treatment of homozygous protein C deficiency by hepatic transplantation. Lancet 1988 0.95
604 Is multiple organ failure a contraindication for liver transplantation in children? Transplant Proc 1987 0.95
605 Applications of the isolated perfused rat liver in transplantation research. J Invest Surg 1988 0.95
606 Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation 1997 0.95
607 Late mortality and morbidity after liver transplantation. Transplant Proc 1987 0.95
608 Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors. Gastroenterology 1986 0.95
609 Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells. Transplant Proc 1988 0.95
610 Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. Ann Surg 1996 0.95
611 Development and organization of a multiple organ transplantation program. Ann Surg 1986 0.95
612 Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc 1991 0.95
613 The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991. J Surg Oncol Suppl 1993 0.95
614 Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers. Transplant Proc 1991 0.95
615 Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation 2002 0.95
616 Endogenous endotoxemia during orthotopic liver transplantation in dogs. Transplant Proc 1989 0.94
617 A microcomputer-based approach to data management: an essential tool in the assessment of trends and results in liver transplantation. Semin Liver Dis 1985 0.94
618 Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation 1987 0.94
619 Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. Transplant Proc 1995 0.94
620 Liver transplantation for hepatoblastoma. The American experience. Ann Surg 1991 0.94
621 Spontaneous arterioenteric fistula after pancreas transplantation. Transplantation 1997 0.94
622 Changes of liver-resident NK cells during liver regeneration in rats. J Immunol 1995 0.94
623 An attempt to reverse diabetes by delayed islet cell transplantation in humans. Transplant Proc 1997 0.94
624 The clinical trial of FK 506 as primary and rescue immunosuppression in pediatric cardiac transplantation. Transplant Proc 1991 0.94
625 The comparative in vitro and in vivo activity of antilymphocyte serum raised by immunization with thymic, splenic, and lymph node lymphocytes. Surgery 1969 0.94
626 Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery 1974 0.94
627 Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology 1988 0.94
628 Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 1994 0.94
629 Lazaroid U-74389G for 48-hour canine liver preservation. Transplantation 1996 0.93
630 Cadaveric renal transplantation under the American organ allocation system. Contrib Nephrol 1989 0.93
631 Effect of bile on cyclosporine absorption in dogs. Res Commun Chem Pathol Pharmacol 1986 0.93
632 Augmenter of liver regeneration enhances the success rate of fetal pancreas transplantation in rodents. Transplantation 1998 0.93
633 The technique of prolonged thoracic duct drainage in transplantation. Surg Gynecol Obstet 1980 0.93
634 Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate. Surgery 1971 0.93
635 Liver transplantation. Ann Intern Med 1966 0.93
636 Steps in immunosuppression for renal transplantation. Kidney Int Suppl 1983 0.93
637 Right trisegmentectomy with a synthetic vena cava graft. Arch Surg 1988 0.93
638 Malignant lymphomas in transplantation patients: a review of the world experience. Int Z Klin Pharmakol Ther Toxikol 1970 0.93
639 FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 1991 0.93
640 Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997 0.93
641 Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl 2001 0.93
642 Liver transplantation for treatment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. Am J Cardiol 1987 0.93
643 Liver replacement after massive hepatic trauma. J Trauma 1987 0.92
644 Clinical intestinal transplantation. Transplant Proc 1993 0.92
645 Obstructing mucocele of the cystic duct after transplantation of the liver. Surg Gynecol Obstet 1989 0.92
646 Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989 0.92
647 Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc 1997 0.92
648 Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation 1997 0.92
649 Percutaneous transhepatic cholangiography rather than ultrasound as a screening test for postoperative biliary complications in liver transplant patients. Transplant Proc 1988 0.92
650 Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin. Clin Exp Immunol 1970 0.92
651 Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000 0.92
652 Complications of sclerotherapy for esophageal varices in liver transplant candidates. Transplant Proc 1990 0.92
653 The effect of prednisone on pancreatic islet autografts in dogs. Surgery 1993 0.92
654 Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis 2004 0.92
655 Pharmacologic modulation of experimental postischemic hepatic function. Ann Surg 1989 0.92
656 Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc 1999 0.92
657 Metabolism of low-density lipoproteins by cultured hepatocytes from normal and homozygous familial hypercholesterolemic subjects. Biochim Biophys Acta 1986 0.92
658 Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology 1989 0.92
659 Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 1999 0.92
660 Obstruction to hepatic venous drainage after liver transplantation: treatment with balloon angioplasty. Radiology 1989 0.92
661 Cause and timing of first allograft failure in orthotopic liver transplantation: a study of 177 consecutive patients. Hepatology 1991 0.91
662 Liver transplantation for Alagille's syndrome. Arch Surg 1993 0.91
663 Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease. Transplantation 1992 0.91
664 A monoclonal antibody (L21-6) recognizing an invariant chain expressed on the cell surface in rats with the exception of the BN (RT1n): a study of tissue and strain distributions. Transplant Proc 1995 0.91
665 Cyclosporine G Analysis and Monitoring by High-Pressure Liquid Chromatography. Transplant Proc 1986 0.91
666 Portal diversion in glycogen storage disease. Surgery 1969 0.91
667 Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998 0.91
668 Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene. Transplantation 2000 0.91
669 Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery 1991 0.91
670 Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc 1973 0.91
671 The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg 1987 0.91
672 Major hepatic resection and portal pressure. Surg Gynecol Obstet 1977 0.91
673 Changes in life-style after liver transplantation. Pediatrics 1988 0.91
674 Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. Transplant Proc 1990 0.91
675 Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A 1995 0.91
676 Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 1994 0.91
677 Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 2004 0.91
678 Human orthotopic liver transplantation: surgical aspects in 393 consecutive grafts. Transplant Proc 1988 0.91
679 The effect of small bowel transplantation on the morphology and physiology of intestinal muscle: a comparison of autografts versus allografts in dogs. Transplantation 1997 0.90
680 Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc 1993 0.90
681 Low rate of Rhesus immunization from Rh-incompatible blood transfusions during liver and heart transplant surgery. Transplantation 1989 0.90
682 Pancreatitis following liver transplantation. Transplantation 1988 0.90
683 Intestinal transplantation in humans under FK 506. Transplant Proc 1993 0.90
684 Protective effect of FK 506 against hepatic ischemia in rats. Transplant Proc 1991 0.90
685 Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. Transplant Proc 1989 0.90
686 Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. Transplant Proc 1994 0.90
687 Total pancreaticoduodenal homotransplantation in dogs immunosuppressed with cyclosporine and steroids. Am J Surg 1984 0.90
688 Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles. World J Surg 2000 0.90
689 Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996 0.90
690 Antibody deposition in liver allografts with chronic rejection. Transplant Proc 1987 0.90
691 Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point system. Clin Transpl 1988 0.90
692 Donor selection and surgical technique for en bloc liver-small bowel graft procurement. Transplant Proc 1993 0.90
693 Improved Cardiac Function Using Cardioplegia During Procurement and Transplantation. Transplant Proc 1983 0.90
694 Prevention of spontaneous diabetes in BB rats with FK 506. Lancet 1990 0.90
695 Renal transplantation at the University of Colorado. Transplantation 1967 0.90
696 Surgical approaches for primary and metastatic liver neoplasms, including total hepatectomy with orthotopic liver transplantation. Prog Clin Cancer 1978 0.90
697 Genotypic analyses of cyclosporine-associated lymphoproliferations. Transplantation 1987 0.90
698 Isolation and primary cultures of human intrahepatic bile ductular epithelium. In Vitro Cell Dev Biol 1988 0.90
699 Arterial mycotic aneurysm and rupture. A potentially fatal complication of pancreas transplantation in diabetes mellitus. Arch Surg 1989 0.90
700 Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology 1992 0.89
701 Liver transplantation for type I and type IV glycogen storage disease. Eur J Pediatr 1993 0.89
702 Extrahepatic complications of liver transplantation. Semin Liver Dis 1985 0.89
703 Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression. Transplant Proc 1991 0.89
704 A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000 0.89
705 Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer 1991 0.89
706 Use of anti-lymphocyte serum to prolong dog homograft survival. Surg Forum 1966 0.89
707 Long-term use of cyclosporine in liver recipients. Reduction of dosages in the first year to avoid nephrotoxicity. Transplantation 1983 0.89
708 Liver rejection and its differentiation from other causes of graft dysfunction. Semin Liver Dis 1985 0.89
709 Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001 0.89
710 FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc 1991 0.89
711 In vivo effect of FK506 on human pancreatic islets. Transplantation 1991 0.89
712 Venous reconstruction of pediatric en-bloc kidneys for transplantation. Transplantation 1990 0.89
713 Hepatic regeneration: implications in fulminant hepatic failure. Int J Artif Organs 1979 0.89
714 Effect of danazol on cyclosporine pharmacokinetics. Transplantation 1988 0.89
715 Human islet allotransplantation under FK 506. Transplant Proc 1991 0.89
716 Immunosuppression with cyclophosphamide in the dog. Clin Exp Immunol 1975 0.89
717 Cadaveric Renal Transplantation With Cyclosporin-A and Steroids. Transplant Proc 1983 0.88
718 Letter: Portacaval shunt in hyperlipidaemia. Lancet 1974 0.88
719 A 14-year experience with kidney transplantation. World J Surg 1977 0.88
720 Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome). Transpl Int 1992 0.88
721 Graft-versus-host disease in fully allogeneic small bowel transplantation: incidence of the disease and strain combinations. Transplant Proc 1993 0.88
722 Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. Transplant Proc 1990 0.88
723 Insulin independence for 58 months following pancreatic islet cell transplantation in a patient undergoing upper abdominal exenteration. Transplant Proc 1995 0.88
724 Modification of xenograft response by selective plasmapheresis. Transplant Proc 1971 0.88
725 Hamster coagulation and serum proteins in rat recipients of hamster xenografts. Transplantation 1993 0.88
726 Cyclosporine trough concentration monitoring in liver transplant patients. Transplant Proc 1986 0.88
727 Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc 1988 0.88
728 Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery 1995 0.88
729 Transmission of fatal herpes simplex infection through renal transplantation. Transplantation 1988 0.88
730 A summary of the status of de novo cancer in transplant recipients. Transplant Proc 1972 0.88
731 Radioisotope scanning in experimental and clinical orthotopic liver transplantation. Surg Gynecol Obstet 1968 0.88
732 Incompatible blood transfusions in liver transplant patients with significant red cell alloantibodies. Transplant Proc 1989 0.88
733 Changes in renal function after liver transplantation under FK 506. Transplant Proc 1991 0.88
734 Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 1995 0.87
735 Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. Transplant Proc 1991 0.87
736 Combined transplantation of the heart and liver. Ann Surg 1985 0.87
737 Red cell antibody problems in 1000 liver transplants. Transfusion 1989 0.87
738 Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation 1997 0.87
739 Small intestinal transplantation for irreversible intestinal failure in children. Dig Dis Sci 1997 0.87
740 HLA alloimmunization and blood requirements in orthotopic liver transplantation. Transplant Proc 1989 0.87
741 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
742 Mixed lymphocyte culture and graft rejection. Surg Forum 1973 0.87
743 Effect of OKT3 on survival and rate of retransplantation. Transplant Proc 1987 0.87
744 Liver failure occurring as a component of exertional heatstroke. Gastroenterology 1991 0.87
745 Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology 1996 0.87
746 Liver transplantation without the use of blood products. Arch Surg 1994 0.87
747 Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 2000 0.87
748 Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. Transplant Proc 1991 0.86
749 Liver procurement for orthotopic transplantation: an analysis of the Pittsburgh experience. Hepatology 1984 0.86
750 Reversal of acute cellular rejection after renal transplantation with Campath-1H. Transplant Proc 2005 0.86
751 The anterior route for arterial graft conduits in liver transplantation. Transpl Int 1989 0.86
752 Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc 1987 0.86
753 Bone marrow augmentation in renal transplant recipients. Transplant Proc 1998 0.86
754 Hyperacute rejection of the kidney in patients with a negative crossmatch. Transplant Proc 1988 0.86
755 Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg 1998 0.86
756 Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 1990 0.86
757 Interaction between FK506 and clotrimazole in a liver transplant recipient. Transplantation 1991 0.86
758 Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc 1999 0.86
759 FK 506 inhibits the development of transplant arteriosclerosis. Transplant Proc 1991 0.86
760 Analysis of anesthetic-related morbidity in human recipients of renal homografts. Anesth Analg 1971 0.86
761 Liver transplantation in patients over sixty years of age. Transplantation 1991 0.86
762 Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc 1998 0.86
763 Clonal characteristics of posttransplant lymphoproliferative disorders. Transplant Proc 1988 0.86
764 Lipid peroxidation is a nonparenchymal cell event with reperfusion after prolonged liver ischemia. J Surg Res 1990 0.86
765 Should the ruptured renal allograft be removed? Arch Surg 1979 0.86
766 Survival of a homologous parathyroid implant in an immunosuppressed patient. Lancet 1973 0.86
767 Fluconazole therapy in transplant recipients receiving FK506. Transplantation 1994 0.86
768 Liver transplantation in patients with previous portasystemic shunt. Am J Surg 1990 0.86
769 Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. J Virol 2001 0.86
770 Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation. Am J Transplant 2011 0.86
771 Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. J Hepatol 1994 0.86
772 Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997 0.86
773 Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 1996 0.86
774 Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. Transplant Proc 1991 0.86
775 Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999 0.85
776 The prospect of organ transplantation in cancer surgery. Proc Natl Cancer Conf 1970 0.85
777 Pseudoaneurysms following orthotopic liver transplantation: clinical and radiologic manifestations. Transplant Proc 1989 0.85
778 Percutaneous transhepatic balloon dilatation of benign biliary strictures. AJR Am J Roentgenol 1987 0.85
779 Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991 0.85
780 Transplantation of the small intestine: the pathologist's perspective. Am J Surg Pathol 1990 0.85
781 Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994 0.85
782 Surgical complications in human orthotopic liver transplantation. Acta Chir Belg 1987 0.85
783 Transport of apolipoproteins A-I and A-II by human thoracic duct lymph. J Clin Invest 1981 0.85
784 Postoperative surgical complications. Gastroenterol Clin North Am 1988 0.85
785 Induction of stable chimerism and elimination of graft-versus-host disease by depletion of T lymphocytes from bone marrow using immunomagnetic beads. Surgery 1989 0.85
786 FK 506: a new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc 1991 0.85
787 Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. J Urol 1992 0.85
788 FK506 in solid organ transplantation. Ther Drug Monit 1995 0.85
789 Protecting the patient's interest. Kidney Int Suppl 1985 0.85
790 Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 1995 0.85
791 Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.85
792 Obesity as a risk factor following cadaveric renal transplantation. Transplantation 1990 0.85
793 Retrograde false channel perfusion: a complication of cardiopulmonary bypass during repair of dissecting aneurysms. Ann Thorac Surg 1970 0.85
794 Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. Nephron 1987 0.85
795 Metabolism of plasma protein fractions after orthotopic homografts and autografts of the dog liver. Surg Forum 1966 0.85
796 Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992 0.85
797 Species-specific cyclosporine metabolism. Transplant Proc 1988 0.85
798 Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplants. Transplant Proc 1987 0.85
799 FK 506 and autoimmune disease: perspective and prospects. Autoimmunity 1992 0.85
800 Delay of the heterograft reaction by selective plasmapharesis. Surg Forum 1970 0.85
801 Acute renal response to large doses of intravenous prednisolone in kidney homograft recipients and in normal subjects. J Lab Clin Med 1971 0.85
802 Significance of blood flow measurement in clinical liver transplantation. Transplant Proc 1989 0.85
803 Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma. J Hepatol 1986 0.85
804 Late complications with gallbladder conduit biliary reconstruction after liver transplantation. Transplantation 1989 0.84
805 Drug-binding proteins in liver transplant patients. J Clin Pharmacol 1988 0.84
806 New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev 1993 0.84
807 Hepatic transplantation. Surgery 1976 0.84
808 Effect of ischemia on the canine large bowel: a comparison with the small intestine. J Surg Res 1996 0.84
809 Candida carriage in the alimentary tract of liver transplant candidates. Transplantation 1994 0.84
810 Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993 0.84
811 Personal reflections in transplantation. Surg Clin North Am 1978 0.84
812 Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation. Transplant Proc 1997 0.84
813 Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc 2002 0.84
814 Spindle cell tumor of the portal vein. J Surg Oncol 1995 0.84
815 The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506. Transplant Proc 1991 0.84
816 The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995 0.84
817 Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999 0.84
818 A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62. J Immunol Methods 1995 0.84
819 Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg 2000 0.84
820 Radioisotope scanning in auxiliary liver transplantation. Surg Gynecol Obstet 1966 0.84
821 Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993 0.84
822 Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation. Hepatology 1985 0.84
823 Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus. Transplantation 1997 0.84
824 The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivo. Transplant Proc 1991 0.84
825 HLA histocompatibility and liver transplant survival. Transplant Proc 1987 0.84
826 Symposium on immunosuppressive drugs. Attributes of clinically used immunosuppressive drugs: possible future uses of antilymphoid sera. Fed Proc 1967 0.84
827 Role of splenectomy in human liver transplantation under modern-day immunosuppression. Dig Dis Sci 1998 0.84
828 Esophageal complications in orthotopic liver transplant patients. Transplantation 1991 0.84
829 Early tolerance in pediatric liver allograft recipients. J Pediatr Surg 1994 0.84
830 Progress in liver transplantation. Adv Surg 1988 0.83
831 Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg 1988 0.83
832 Renal transplantation under FK 506 in African-Americans: early experience. Transplant Proc 1993 0.83
833 Anti-A production by a group O spleen transplanted to a group A recipient. Vox Sang 1985 0.83
834 Crystallization and preliminary crystallographic data for the augmenter of liver regeneration. Acta Crystallogr D Biol Crystallogr 1997 0.83
835 Serum -fetoprotein in hepatoma patients after liver transplantation. Gastroenterology 1971 0.83
836 A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 1996 0.83
837 Orthotopic liver transplantation and the cytosolic estrogen-androgen receptor status of the liver: the influence of the sex of the donor. Hepatology 1989 0.83
838 Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning. Transplant Proc 2004 0.83
839 S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am J Pathol 1989 0.83
840 TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transpl Immunol 1996 0.83
841 Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection? Transpl Int 1988 0.83
842 A new liver perfusion and preservation system for transplantation research in large animals. J Invest Surg 1990 0.83
843 Bacterial translocation in clinical intestinal transplantation. Transplant Proc 2000 0.83
844 Peribiliary vascular diseases in rejected livers; computer-aided three-dimensional reconstruction and morphometry. Transplant Proc 1991 0.83
845 Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology 1995 0.83
846 Liver transplantation for primary biliary cirrhosis. Semin Liver Dis 1989 0.83
847 Oxygen and CO-2 content in the splanchnic and nonsplanchnic blood of dogs with portacaval transposition. Surgery 1966 0.83
848 Partial dearterialization of the liver allograft. Transpl Int 1990 0.83
849 Auxiliary homotransplantation of the canine liver with the use of a "reverse" Welch technique. Surgery 1968 0.83
850 Experimental and clinical observations after homotransplantation of the whole liver. Rev Int Hepatol 1965 0.83
851 Five cases and five unusual indications for autogenic renal transplantation. Acta Chir Scand 1975 0.83
852 Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients. Cell Transplant 1994 0.83
853 Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes. Transplantation 1997 0.83
854 Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Am J Hosp Pharm 1992 0.83
855 Reperfusion injury following cold ischemia activates rat liver Kupffer cells. Transplant Proc 1991 0.83
856 Selected topics on antilymphocyte serum. Fed Proc 1970 0.83
857 Implied consent for cadaveric organ donation. JAMA 1984 0.83
858 The relationship of systemic hemodynamics and oxygen consumption to early allograft failure after liver transplantation. Transpl Int 1993 0.83
859 The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion 1993 0.83
860 Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med 1988 0.83
861 Testicular complications following renal transplantation. Ann Surg 1972 0.83
862 Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation 2000 0.83
863 Liver transplant rejection: angiographic findings in 35 patients. AJR Am J Roentgenol 1987 0.83
864 FK 506 in the management of nephrotic syndrome after renal transplantation. Transplant Proc 1993 0.83
865 A hundred years of the hepatotrophic controversy. Ciba Found Symp 1977 0.82
866 Cyclosporine pharmacokinetic profiles in liver, heart, and kidney transplant patients as determined by high-performance liquid chromatography. Transplant Proc 1986 0.82
867 Experience with resection of primary hepatic malignancy. Surg Clin North Am 1989 0.82
868 Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells. Transplant Proc 1995 0.82
869 Portacaval shunt and hyperlipidemia. Arch Surg 1978 0.82
870 Goodpasture's syndrome. Treatment with nephrectomy and renal transplantation. Arch Surg 1971 0.82
871 The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc 1995 0.82
872 Lack of susceptibility of baboons to infection with hepatitis B virus. Transplantation 1996 0.82
873 Cellular transplants. Transplant Proc 1991 0.82
874 HLA matching effect in liver transplantation. Transplant Proc 1992 0.82
875 Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transpl Int 1994 0.82
876 Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant Proc 1991 0.82
877 Insulin, glucagon, and the control of hepatic structure, function, and capacity for regeneration. Metabolism 1976 0.82
878 Reducing the length of stay after kidney transplantation--the intensive outpatient unit. Clin Transplant 1998 0.82
879 Renal transplantation in patients 65 years old or older. J Urol 1992 0.82
880 Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation. Transplant Proc 1997 0.82
881 Recovery from hepatorenal syndrome after successful orthotopic liver transplantation. Surg Forum 1973 0.82
882 The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc 2000 0.82
883 Induction of graft acceptance after dog kidney or liver transplantation. Transplant Proc 1990 0.82
884 The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc 2000 0.82
885 Hepatic osteodystrophy after liver transplantation in a patient with primary biliary cirrhosis. Am J Gastroenterol 1983 0.82
886 Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. Transplant Proc 1991 0.82
887 Distal splenorenal shunt for portal vein thrombosis after liver transplantation. Am J Gastroenterol 1989 0.82
888 Treatment of Cogan's syndrome with FK 506: a case report. Transplant Proc 1991 0.82
889 Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc 1991 0.82
890 Modification of established rejection of canine kidney and liver homografts with antilymphocyte gamma-G globulin. Surgery 1969 0.82
891 The complement system in renal homograft recipents. Surgery 1972 0.82
892 Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation 1995 0.82
893 Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc 2001 0.82
894 An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol 1997 0.82
895 Tube choledochoureterostomy: a simple method for bile diversion. J Invest Surg 1990 0.82
896 In vitro characterization of rat bone marrow-derived dendritic cells and their precursors. J Leukoc Biol 1996 0.82
897 "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation 1996 0.82
898 A DEAE-cellulose batch technique for antilymphyocyte globulin preparation. Surg Forum 1968 0.82
899 Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs. Res Commun Chem Pathol Pharmacol 1989 0.82
900 Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg 1999 0.81
901 Cytomegalovirus infection and gastric emptying. Transplantation 1992 0.81
902 Estrogen binding protein activity in Morris hepatoma 7777 compared with normal rat liver. Gastroenterology 1984 0.81
903 Hepatic artery pseudoaneurysm ligation after orthotopic liver transplantation--a report of 7 cases. Transplantation 1992 0.81
904 A Novel Model of Acute Hepatic Failure in Dogs With Implications for Transplantation Research. Transplant Proc 1988 0.81
905 Normotest and abnormal prothrombin in liver transplantation. Liver 1995 0.81
906 Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation. Transplantation 1989 0.81
907 Survival after liver transplantation in patients with hepatocellular carcinoma. Princess Takamatsu Symp 1995 0.81
908 Risk factors and predictive indexes of early graft failure in liver transplantation. Ital J Gastroenterol 1996 0.81
909 Association of HLA Compatibility and Decreased Liver Transplant Survival. Transplant Proc 1988 0.81
910 FK 506 (Tacrolimus) metabolism by rat liver microsomes and its inhibition by other drugs. Res Commun Chem Pathol Pharmacol 1994 0.81
911 Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation 1998 0.81
912 Cyclosporine augments hepatic regenerative response in rats. Dig Dis Sci 1990 0.81
913 Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc 2001 0.81
914 Is hepatic artery thrombosis after liver transplantation really a surgical complication? Transplant Proc 1989 0.81
915 Orthotopic liver transplantation for fulminant and subacute hepatic failure. Gastroenterol Clin North Am 1988 0.81
916 A simplified technique for the treatment of simple pleural effusions. Surg Gynecol Obstet 1987 0.81
917 Effect of ribonucleic acid perfusion on canine kidney and liver homograft survival. Surgery 1968 0.81
918 Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver. Inhibitor effect of estrogen on binding and mitogenic effect of epidermal growth factor. Gastroenterology 1987 0.81
919 Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc 1998 0.81
920 Heterogenous distribution of chimerism produced by rat organ and bone marrow allotransplantation. Transplantation 1996 0.81
921 Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol 1992 0.81
922 Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 1992 0.81
923 Extraction ratio of cyclosporine in a liver transplant patient with organ rejection. J Pharm Sci 1985 0.81
924 Effect of FK 506 on spontaneous diabetes in BB rats. Diabetes 1990 0.81
925 Orthotopic liver transplantation for massive hepatic lymphangiomatosis. Surgery 1988 0.81
926 The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons. J Surg Res 1980 0.81
927 Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. Transplantation 1994 0.81
928 Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007 0.81
929 Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. Transplant Proc 1991 0.81
930 Modified simple cold storage of rat livers with UW solution. Transplantation 1994 0.81
931 Impaired clearance of ceftizoxime and cefotaxime after orthotopic liver transplantation. Antimicrob Agents Chemother 1987 0.80
932 Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat. Transplant Proc 1993 0.80
933 Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg 2000 0.80
934 Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation. Transplantation 1990 0.80
935 Hypernatremia. Complication of renal homotransplantation. Arch Intern Med 1971 0.80
936 Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. Hepatology 1993 0.80
937 Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation 1999 0.80
938 Liver transplantation for tyrosinemia. A review of 10 cases from the University of Pittsburgh. Dig Dis Sci 1990 0.80
939 Morphologic and biochemical changes in dogs after portacaval shunt plus bile fistula or ileal bypass: failure of bile fistula or ileal bypass to prevent hepatocyte atrophy. Hepatology 1983 0.80
940 Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation. Transplant Proc 1989 0.80
941 Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 1993 0.80
942 Microchimerism: inaccurate literature citations. Transplantation 1996 0.80
943 Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy. Transplant Proc 1997 0.80
944 Endotoxemia is associated with renal dysfunction in liver transplantation recipients during the first postoperative week. Hepatogastroenterology 1995 0.80
945 Lipid peroxidation, brush border, and neutrophil enzyme activity after small bowel preservation: a comparison of preservation solutions. Transplant Proc 1992 0.80
946 Ethical problems in organ transplantation. A clinician's point of view. Ann Intern Med 1967 0.80
947 Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc 1997 0.80
948 Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. Liver Transpl Surg 1998 0.80
949 Procurement of liver allografts from non-heart beating donors. Transplant Proc 1990 0.80
950 A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. Transplant Proc 1990 0.80
951 Liver transplantation in patients with situs inversus. Clin Transplant 1990 0.80
952 Disturbance of microcirculation associated with prolonged preservation of dog livers under University of Wisconsin solution. Transplant Proc 1993 0.80
953 Pancreas transplantation without antibody therapy. Transplant Proc 1998 0.80
954 Late spontaneous rupture in a homografted kidney. A case report. Arch Surg 1974 0.80
955 Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Clin Transplant 1999 0.80
956 Changes in serum potassium and pH during clinical and experimental liver transplantation. Surgery 1971 0.80
957 Liver transplantation in the management of bleeding oesophageal varices. Baillieres Clin Gastroenterol 1992 0.80
958 Successful reconstruction of late portal vein stenosis after hepatic transplantation. Arch Surg 1989 0.80
959 Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. Am J Kidney Dis 1988 0.80
960 Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996 0.80
961 Vascularized composite tissue mandibular transplantation in dogs. Transplant Proc 1997 0.80
962 Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int 1992 0.80
963 Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 1998 0.80
964 Liver support/transplants and artificial organs. Trans Am Soc Artif Intern Organs 1983 0.80
965 FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991 0.80
966 Preservation of livers with UW or Euro-Collins' solution. Transplantation 1988 0.80
967 Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc 1995 0.80
968 FK 506 prevents spontaneous diabetes in the BB rat. Transplant Proc 1991 0.80
969 Beta-glucan reflects liver injury after preservation and transplantation in dogs. J Invest Surg 1999 0.80
970 Does previous abdominal surgery alter the outcome of pediatric patients subjected to orthotopic liver transplantation? Gastroenterology 1986 0.79
971 FK 506 pre-treatment is associated with reduced levels of tumor necrosis factor and interleukin 6 following hepatic ischemia/reperfusion. J Hepatol 1993 0.79
972 Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity. Transplantation 1998 0.79
973 Mechanisms of hamster kidney graft rejection in the rat. Transplant Proc 1994 0.79
974 FK 506 in solid organ transplantation. Transplant Proc 1994 0.79
975 Past and future prospects of orthoptic liver transplantation. Arch Surg 1981 0.79
976 Prolonged rat cardiac preservation with UW lactobionate solution. Transplant Proc 1989 0.79
977 Landmark perspective: The landmark identical twin case. JAMA 1984 0.79
978 The effect of FK 506 on small intestine allotransplantation in the rat. Transplant Proc 1990 0.79
979 Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients. Transplantation 1997 0.79
980 Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro. J Hepatol 1989 0.79
981 Surgical technique of orthotopic liver transplantation. Gastroenterol Clin North Am 1988 0.79
982 Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species. Transplant Proc 2001 0.79
983 Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation 1998 0.79
984 Influence of graft perfusion pressure on graft viability after small bowel preservation and transplantation. Transplant Proc 1996 0.79
985 Isolation of an autocrine growth factor from hepatoma HTC-SR cells. J Cell Physiol 1987 0.79
986 Liver regeneration in rats treated with the antiandrogen flutamide. J Invest Surg 1988 0.79
987 The first report of orthotopic liver transplantation in the Western world. Am J Transplant 2012 0.79
988 Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts. Transplantation 1990 0.79
989 Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomy. Dig Dis Sci 1990 0.79
990 Conservation of the liver. Transplant Proc 1969 0.79
991 Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology 1994 0.79
992 Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. Transplant Proc 1990 0.79
993 Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc 1995 0.79
994 Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997 0.79
995 Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc 1993 0.79
996 Chimerism after whole organ transplantation: its relationship to graft rejection and tolerance induction. Curr Opin Nephrol Hypertens 1994 0.79
997 Current status of liver transplantation. South Med J 1977 0.79
998 Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities. Transplant Proc 1992 0.79
999 Transplantation of the liver. Surg Clin North Am 1977 0.79
1000 Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc 1995 0.79
1001 Further studies on hepatic stimulatory substance (SS) after partial hepatectomy. J Surg Res 1980 0.79
1002 "Pants" vein jump graft for portal vein and superior mesenteric vein thrombosis in transplantation of the liver. J Am Coll Surg 1996 0.79
1003 Detection of pancreatic islet tissue following islet allotransplantation in man. Transplantation 1991 0.79
1004 Bench surgery and renal autotransplantation in the pediatric patient. J Pediatr Surg 1975 0.79
1005 The dichotomous functions of passenger leukocytes in solid-organ transplantation. Adv Nephrol Necker Hosp 1995 0.79
1006 Serum parathyroid hormone levels and renal handling of phosphorus in patients with chronic renal disease. J Clin Endocrinol Metab 1972 0.79
1007 Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc 1997 0.79
1008 The Denver-Pittsburgh liver transplant series. Clin Transpl 1987 0.79
1009 Destruction of endothelial cells by humoral factors obtained from recipients of xenografts. Transplant Proc 1994 0.79
1010 Organ transplantation, past and present. Surg Clin North Am 1968 0.79
1011 Myocardial ischemia after orthotopic liver transplantation. Am J Cardiol 1994 0.79
1012 Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. Transplant Proc 1981 0.79
1013 Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. Am J Surg Pathol 1996 0.79
1014 Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc 1980 0.79
1015 Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody. J Invest Surg 1989 0.79
1016 FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats. Transplant Proc 1992 0.79
1017 Intraoperative blood transfusion requirements and deficient hemostasis in highly alloimmunized patients undergoing liver transplantation. Transplant Proc 1988 0.79
1018 Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. J Invest Surg 1996 0.79
1019 Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. Transpl Immunol 1993 0.79
1020 Donor gender does not affect liver transplantation outcome in children. Dig Dis Sci 1990 0.79
1021 Pharmacokinetics of ceftriaxone in liver-transplant recipients. J Clin Pharmacol 1991 0.79
1022 Propagation of dendritic cell progenitors from mouse liver and their in vivo migration to T-dependent areas of allogeneic lymphoid tissue. Transplant Proc 1994 0.79
1023 Transplantation in children. Surg Clin North Am 1976 0.79
1024 Identification of the Aldehydic Metabolites. Transplant Proc 1988 0.79
1025 Letter: Liver transplantation for Wilson's disease. Lancet 1975 0.79
1026 Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. Alcohol Clin Exp Res 1989 0.79
1027 Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc 1997 0.79
1028 Two-year experience with FK 506 in pediatric patients. Transplant Proc 1993 0.78
1029 Successful liver transplantation for isoniazid-induced hepatic failure--a case report. Transplantation 1994 0.78
1030 Gastrointestinal motility in the immediate postoperative period after intestinal transplantation, with special reference to acute rejection. Transplant Proc 1994 0.78
1031 Infections in pediatric liver recipients treated for acute rejection. Transplant Proc 1989 0.78
1032 Metabolic bone disease in chronic renal failure. II. Renal transplant patients. Am J Pathol 1975 0.78
1033 Blocking of the B7-CD28 pathway increases the capacity of FasL+ (CD95L+) dendritic cells to kill alloactivated T cells. Adv Exp Med Biol 1997 0.78
1034 Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1. Transplant Proc 1992 0.78
1035 Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin. Transplant Proc 1992 0.78
1036 Reversal of hepatic alpha-1-antitrypsin deposition after portacaval shunt. Lancet 1983 0.78
1037 Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Transplant Proc 1993 0.78
1038 Primary cultures of human intrahepatic (biliary) epithelial cells. Transplant Proc 1988 0.78
1039 Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc 2000 0.78
1040 Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplant Proc 1996 0.78
1041 Liver preservation with lidoflazine and the University of Wisconsin solution: a dose-finding study. Transplantation 1993 0.78
1042 Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc 1995 0.78
1043 Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. Transplant Proc 1991 0.78
1044 Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. Transplant Proc 1996 0.78
1045 Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology 1999 0.78
1046 A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation 2001 0.78
1047 Radiology and organ transplantation. New Horizons for Radiologists Lecture. Radiology 1970 0.78
1048 Portacaval shunt for glycogen storage disease and hyperlipidaemia. Ciba Found Symp 1977 0.78
1049 Hematopoietic reconstitution by transplanted grafts in lethally irradiated recipients. Transplant Proc 1997 0.78
1050 In vitro effects of cyclosporine and FK 506 on the renal cortex. Transplant Proc 1991 0.78
1051 Role of xanthine-oxidase system in mucosal injury after intestinal preservation and transplantation. Transplant Proc 1993 0.78
1052 Conjugative drug metabolism in liver transplant patients. Transplant Proc 1989 0.78
1053 Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995 0.78
1054 Arteriography during ex vivo renal perfusion. A complication. Urology 1973 0.78
1055 Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. Transplantation 1990 0.78
1056 Isolation of 10 cyclosporine metabolites from human bile. Drug Metab Dispos 1989 0.78
1057 Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. Transplant Proc 1991 0.78
1058 Will live organ donations no longer be justified? Hastings Cent Rep 1985 0.78
1059 Cold preservation of the human colon and ileum with University of Wisconsin solution. Clin Transplant 1999 0.78
1060 Hemodynamic and biochemical changes during normothermic and hypothermic sanguinous perfusion of the porcine hepatic graft. Transplantation 1990 0.78
1061 Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. Transplantation 1996 0.78
1062 Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy. Ann Nucl Med 1991 0.78
1063 Intestinal transplantation in children: five-year experience. Transplant Proc 1996 0.78
1064 Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991-1995. Transplant Proc 1997 0.78
1065 Hepatic Homograft Survival in Pediatric Orthotopic Liver Transplantation with Cyclosporine and Steroids. Transplant Proc 1983 0.78
1066 Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483. J Am Coll Surg 1998 0.78
1067 Renal transplantation in baboons under FK 506. Transplant Proc 1990 0.78
1068 Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. Arch Dermatol 1994 0.78
1069 Regional cancer chemotherapy for advanced stage hepatocellular carcinoma. J Surg Oncol Suppl 1993 0.78
1070 Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia. Transplant Proc 2000 0.78
1071 Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplantation 1997 0.78
1072 Current status of intestinal transplantation. Adv Surg 1994 0.78
1073 Glucose metabolism during liver transplantation in dogs. Anesth Analg 1987 0.78
1074 Changes of serum potassium during renal homotransplantation. Arch Surg 1970 0.78
1075 Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs. Transplant Proc 1987 0.78
1076 Transmission of HCV by organ transplantation. N Engl J Med 1992 0.78
1077 Cyclosporine-steroid combination therapy in 84 cadaveric renal transplants. Am J Kidney Dis 1985 0.78
1078 Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC). Dig Dis Sci 1991 0.78
1079 Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. Transplant Proc 1999 0.78
1080 Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes. Transplant Proc 1989 0.78
1081 The two-way paradigm of transplantation immunology. Clin Immunol Immunopathol 1996 0.78
1082 Experimental allergic thyroiditis in rats: suppression by heterologous (rabbit) anti-lymphocyte sera to lymph node, thymic and splenic lymphocytes. Clin Exp Immunol 1970 0.78
1083 Intestinal transplantation. Annu Rev Med 1994 0.78
1084 Effluent levels of hyaluronic acid can predict ultimate graft outcome after clinical liver transplantation: a prospective series. Transplant Proc 1993 0.78
1085 Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc 2000 0.78
1086 Idiopathic hemochromotosis and alpha-1-antitrypsin deficiency: coexistence in a family with progressive liver disease in the proband. Hepatology 1983 0.78
1087 Lymphapheresis in organ transplantation: preliminary report. Prog Clin Biol Res 1982 0.78
1088 [Organ transplantation. With special reference to the liver]. Langenbecks Arch Chir 1971 0.78
1089 Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc 1996 0.78
1090 Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. Transplant Proc 1993 0.77
1091 Identification of donor hematopoietic progenitor cells after allogeneic liver transplantation. Transplant Proc 1997 0.77
1092 Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc 1997 0.77
1093 Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest 1996 0.77
1094 Exposure to type-I collagen induces maturation of mouse liver dendritic cell progenitors. Adv Exp Med Biol 1995 0.77
1095 Interferon therapy of hepatitis following liver transplantation under FK 506 or cyclosporine. Transplant Proc 1991 0.77
1096 Intestinal transplantation: 4-year experience. Transplant Proc 1995 0.77
1097 Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Transplant Proc 1998 0.77
1098 The nature of antiplatelet activity in antilymphoblast ALG--with special reference to cross-reacting antibody, immunochemical characterization, and Coombs' positive thrombocytopenia in ALG-treated renal recipients. Clin Exp Immunol 1972 0.77
1099 Cold ischemia time vs outcome of human liver transplantation using UW solution. Transplant Proc 1991 0.77
1100 A modified apparatus for dual, sterilized, isolated perfusion of the rat liver. J Invest Surg 1990 0.77
1101 A look ahead at transplantation. J Surg Res 1970 0.77
1102 Correlation between dose and level of cyclosporine after orthotopic liver transplantation. Transplant Proc 1989 0.77
1103 Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras. Transplant Proc 1992 0.77
1104 Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts. Transplant Proc 1996 0.77
1105 Renal isotransplantation without immunosuppression. Ann Surg 1980 0.77
1106 Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection. Transplantation 1999 0.77
1107 Acute effect of prednisolone on renal handling of sodium. Am J Physiol 1973 0.77
1108 Changing perspectives on liver transplantation in 1988. Clin Transpl 1988 0.77
1109 Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc 1998 0.77
1110 Liver transplantation at the University of Pittsburgh, 1984 to 1990. Clin Transpl 1991 0.77
1111 The hepatic artery in orthotopic liver transplantation. Helv Chir Acta 1988 0.77
1112 Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis. J Autoimmun 1992 0.77
1113 Hepatic vascular exclusion and hepatic resection. Surgery 1984 0.77
1114 Does hyperprolactinemia affect hepatic regeneration independent of sex steroids? J Lab Clin Med 1988 0.77
1115 Effect of HLA mismatch in African-Americans. Transplantation 1998 0.77
1116 Hospitalization and readmission of intestinal transplantation recipients. Transplant Proc 1994 0.77
1117 Inhibition of free radical generation and improved survival by protection of the hepatic microvascular endothelium by targeted erythrocytes in orthotopic rat liver transplantation. Transplantation 1990 0.77
1118 Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg 1999 0.77
1119 Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506. Transplant Proc 1991 0.77
1120 Effect of race upon organ donation and recipient survival in liver transplantation. Dig Dis Sci 1990 0.77
1121 Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo. Hepatology 1991 0.77
1122 Biliary tract complications in orthotopic adult liver transplantation. Am J Surg 1989 0.77
1123 Ex vivo renal perfusion and autotransplantation in treatment of calculous disease or abdominal aortic aneurysm. Urology 1975 0.77
1124 Multivisceral allotransplantation in pigs. Transplant Proc 1996 0.77
1125 Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc 1997 0.77
1126 Posttransplant donor-specific T-lymphocytotoxic antibody in liver transplant patients with a positive crossmatch. Transplant Proc 1992 0.77
1127 Stoma-related variceal bleeding: an under-recognized complication of biliary atresia. J Pediatr Surg 1988 0.77
1128 Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. Transplant Proc 1995 0.77
1129 Effect of tamoxifen on hepatic regeneration in male rats. Dig Dis Sci 1989 0.77
1130 Kidney transplantation in Pittsburgh: experience and innovations. Clin Transpl 1987 0.77
1131 The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Clin Transpl 1989 0.77
1132 Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (F344 rat to B10 mouse). Transplant Proc 1992 0.77
1133 Cellular composition of islet cell suspensions for transplantation. Transplant Proc 1992 0.77
1134 Evolution of surgical techniques in clinical intestinal transplantation. Transplant Proc 1994 0.77
1135 Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplant Proc 1999 0.76
1136 Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc 2000 0.76
1137 Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation 1973 0.76
1138 Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences. Transplant Proc 1993 0.76
1139 Heteroagglutinins and their significance in baboon hepatic xenotransplantation. Transplantation 1995 0.76
1140 Discordance between glucokinase activity and insulin and glucagon receptor changes occurring during liver regeneration in the rat. Horm Metab Res 1984 0.76
1141 Clinical considerations in orthotopic liver transplantation. Radiol Clin North Am 1987 0.76
1142 Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. Transplant Proc 1994 0.76
1143 Xenobiotics, chimerism and the induction of tolerance following organ transplantation. Ther Immunol 1994 0.76
1144 The influence of liver dysfunction on cyclosporine pharmacokinetics--a comparison between 70 per cent hepatectomy and complete bile duct ligation in dogs. Jpn J Surg 1989 0.76
1145 Response to hepatitis B vaccination by liver transplant candidates. Dig Dis Sci 1992 0.76
1146 Parvovirus B19 infection causing pure red cell aplasia in a recipient of pediatric donor kidneys. Transplantation 1993 0.76
1147 Improvement in cognitive functioning of alcoholics following orthotopic liver transplantation. Alcohol Clin Exp Res 1991 0.76
1148 Radionuclides in the postoperative management of orthotopic human organ transplantation. Radiology 1969 0.76
1149 Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. Transplant Proc 1991 0.76
1150 Effect of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver. Transplant Proc 1997 0.76
1151 Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991 0.76
1152 Effect of FK506 on rat Leydig cell function--in vivo and in vitro study. Metabolism 1994 0.76
1153 Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc 1993 0.76
1154 Sterility of bile in multiple-organ donors. Transplantation 1990 0.76
1155 Dialysis in liver failure and liver transplantation. Transplant Proc 1993 0.76
1156 Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant 1993 0.76
1157 Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int 1995 0.76
1158 Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc 1999 0.76
1159 Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice. Transplantation 1991 0.76
1160 Vanishing bile duct syndrome after liver transplantation: alloreactivity or viral reactivity? Transplant Proc 1995 0.76
1161 Splenic artery aneurysms occurring in liver transplant recipients. Transplantation 1991 0.76
1162 Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex) 1998 0.76
1163 Improved survival with cytomegalovirus infection after intestinal transplantation in children. Transplant Proc 1996 0.76
1164 The art of tolerance. Nat Med 1998 0.76
1165 Glucose homeostasis is regulated by donor islets in xenografts. Transplant Proc 1992 0.76
1166 Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up. Transplant Proc 1997 0.76
1167 Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. Arch Surg 1990 0.76
1168 Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. Transplant Proc 1991 0.76
1169 Pancreatic hormones and amino acid levels following liver transplantation. Hepatology 1987 0.76
1170 Hamster-to-rat liver xenografts protect extrahepatic organs from rejection. Transplant Proc 1993 0.76
1171 Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc 1997 0.76
1172 Orthotopic liver transplantation in man. Transplant Proc 1969 0.76
1173 Cyclosporine measurement by FPIA, PC-RIA, and HPLC following liver transplantation. Transplant Proc 1990 0.76
1174 An improved technique for isolated perfusion of rat livers and an evaluation of perfusates. J Surg Res 1992 0.76
1175 Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. Transplant Proc 1995 0.76
1176 Infections after liver transplantation: risk factors and prevention. Transplant Proc 1991 0.76
1177 Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc 2001 0.76
1178 Cellular transplantation and gene therapy. Clin Transplant 1993 0.75
1179 Between Scylla and Charybdis. Ann Surg 1995 0.75
1180 Portacaval shunt in three children with alpha-1-antitrypsin deficiency and cirrhosis: 9 to 12 1/3 years later. Hepatology 1990 0.75
1181 The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 1991 0.75
1182 Liver transplantation in patients with Langerhans' cell histiocytosis. Transplantation 1990 0.75
1183 Acute alteration of plasma renin activity by large doses of intravenous prednisolone. Proc Soc Exp Biol Med 1972 0.75
1184 Outcome of human islet isolation and allotransplantation in 20 consecutive cases. Diabetes Nutr Metab 1992 0.75
1185 Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc 1996 0.75
1186 Lazaroid U74006F for canine small bowel preservation. Transplant Proc 1996 0.75
1187 Medical, ethical, and legal implications of current trends in clinical transplantation: an assessment of the respective roles of government and the private sector in the regulation of transplantation. Transplant Proc 1987 0.75
1188 Posttransplant diabetes in pediatric recipients on tacrolimus. Transplantation 1999 0.75
1189 Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. Transplant Proc 1996 0.75
1190 Surgery: art or science? Birth of organ transplantation. Chirurgie 1998 0.75
1191 Surgical approaches to primary and metastatic liver neoplasms. Int J Radiat Oncol Biol Phys 1976 0.75
1192 Laparoscopic approach for islet cell transplantation. Transplant Proc 1992 0.75
1193 Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. Gastroenterology 1987 0.75
1194 Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994 0.75
1195 Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc 1995 0.75
1196 Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. Transplant Proc 1997 0.75
1197 Human islet isolation and transplantation in chronic pancreatitis using the automated method. Transplant Proc 1992 0.75
1198 Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. Transplant Proc 1993 0.75
1199 Proceedings: The effect of immunosuppression on cancer. Proc Natl Cancer Conf 1972 0.75
1200 Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression. Transplant Proc 1991 0.75
1201 Effect of FK 506 on function of human islets of Langerhans. Transplant Proc 1991 0.75
1202 Hepatectomy in children. Int Adv Surg Oncol 1982 0.75
1203 Effect of Chronic Therapy on Absorption and Disposition of Cyclosporine. Transplant Proc 1988 0.75
1204 Transplantation of the kidney. Med Times 1967 0.75
1205 Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. Transplant Proc 1994 0.75
1206 The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver. J Invest Surg 1989 0.75
1207 Effect of the immunosuppressant FK 506 on insulin release from adult rat islets of Langerhans. Transplant Proc 1991 0.75
1208 Comparison of various lazaroid compounds for protection against ischemic liver injury. Transplant Proc 1997 0.75
1209 Baboon pancreatic islet isolation and transplantation. Transplant Proc 1994 0.75
1210 The role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matching. Clin Transpl 1993 0.75
1211 Complement activation correlates with graft damage in baboon-to-human liver xenotransplantation. Transplant Proc 1994 0.75
1212 An Analysis of the Causes of Death After Pediatric Liver Transplantation. Transplant Proc 1988 0.75
1213 A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol 1998 0.75
1214 The influence of organ supply and demand pressures upon the "primum non nocere" principle in living-donor transplantation. Clin Transpl 1994 0.75
1215 The pharmacodynamics of pentobarbital following FK 506 therapy. Transplant Proc 1991 0.75
1216 Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation. Cell Transplant 1996 0.75
1217 [Renal excretion of bivalent ions after renal homotransplantation]. J Urol Nephrol (Paris) 1972 0.75
1218 High-risk donors: expanding donor criteria. Transplant Proc 1999 0.75
1219 The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc 1991 0.75
1220 Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci 1994 0.75
1221 Response of cultured hepatocytes to a hepatomitogen after initiation by conditioned medium or other factors. Cancer Res 1989 0.75
1222 Portal diversion. Treatment for glycogen storage disease and hyperlipemia. JAMA 1975 0.75
1223 The influence of matching in living-related transplants. Transplantation 1990 0.75
1224 Influence of donor-recipient strain combinations on immunologic responses after allogeneic rat small bowel transplantation. Transplant Proc 1994 0.75
1225 Diurnal variation in cyclosporine kinetics. Ther Drug Monit 1986 0.75
1226 The long-term efficacy of multivisceral transplantation. Transplant Proc 2000 0.75
1227 Frequency of kidney rejection in diabetic patients undergoing simultaneous kidney and pancreatic islet cell transplantation. Transplantation 1993 0.75
1228 Tacrolimus rescue therapy for renal transplant rejection. Transplant Proc 1996 0.75
1229 Improved method of porcine renal allografting for transplantation research. J Invest Surg 1991 0.75
1230 Perioperative donor bone marrow infusion in recipients of organ allografts. Transplant Proc 1997 0.75
1231 Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases. Transplant Proc 1992 0.75
1232 Ischemia/reperfusion injury induces chronic changes in the small bowel. Transplant Proc 2000 0.75
1233 Effects of hepatectomy on the disappearance rate of lidocaine from blood in man and dog. Anesth Analg 1971 0.75
1234 Loyal Davis, surgery of the liver and transplantation of the kidney. Surg Gynecol Obstet 1983 0.75
1235 The immunolymphatic theory of chronic rejection. Transplant Proc 1997 0.75
1236 Louv Med 1973 0.75
1237 Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplant Proc 2002 0.75
1238 Posttransplant hypertension in blacks versus nonblacks. Transplant Proc 1993 0.75
1239 Steroid metabolism in liver transplant patients. Transplant Proc 1989 0.75
1240 Racial differences in organ donation, recipient diseases, and survival following liver transplantation. Transplant Proc 1989 0.75
1241 Radiographic features of liver allograft rejection. Gastrointest Radiol 1986 0.75
1242 Abnormal gastric emptying after intestinal transplantation. Transplant Proc 1994 0.75
1243 Loss of serum bicarbonate after discordant liver xenotransplantation. Transplant Proc 2000 0.75
1244 Relationship between intracellular adenosine triphosphate, cytosolic-free calcium and cytotoxicity in hepatocytes exposed to anoxia/reoxygenation. Transplant Proc 1992 0.75
1245 Histiocytic Lymphoma in Renal Transplant Patients Receiving Cyclosporine. Transplant Proc 1983 0.75
1246 The Lewis blood group system in liver transplantation. Transplant Proc 1987 0.75
1247 Glutamine metabolism of intestine grafts: influence of mucosal injury by prolonged preservation and transplantation. Transplant Proc 1996 0.75
1248 Intestinal retransplantation. Transplant Proc 1996 0.75
1249 Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms. Transplant Proc 1991 0.75
1250 Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection. Transplant Proc 1998 0.75
1251 Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice. Transplant Proc 1992 0.75
1252 Histologic finding of pancreatic islet tissue following intraportal human islet allotransplantation. Transplant Proc 1992 0.75
1253 Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. Transplant Proc 1996 0.75
1254 Metabolic changes in the recipient after successful liver xenotransplantation in the rat. Transplant Proc 1994 0.75
1255 Quantitative analysis of microchimerism with Y-chromosome-specific PCR in canine small bowel transplantation. Transplant Proc 2000 0.75
1256 The succession from kidney to liver transplantation. Transplant Proc 1981 0.75
1257 Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 2001 0.75
1258 Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma. Transplant Proc 1988 0.75
1259 Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999 0.75
1260 Orthotopic liver transplantation for fulminant and subacute hepatic failure. ASAIO Trans 1989 0.75
1261 Frozen section of liver biopsy for the evaluation of liver allografts. Transplant Proc 1990 0.75
1262 Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. Transplant Proc 1991 0.75
1263 Adenoviral-mediated gene delivery to liver isografts: improved model of ex vivo gene transfer. Transplant Proc 1999 0.75
1264 Proceedings: Transplantation of extrarenal organs. Proc Natl Cancer Conf 1972 0.75
1265 Hepatic transplantation, 1975. Postgrad Med J 1976 0.75
1266 Lymphoma and hypercalcemia in a pediatric orthotopic liver transplant patient. Transplantation 1989 0.75
1267 A simplified method of transhepatic intubation. Surg Gynecol Obstet 1980 0.75
1268 Hepatitis viral markers in patients undergoing primary liver transplants. Dig Dis Sci 1993 0.75
1269 Long-term insulin requirement after liver transplantation with FK 506 in American veterans. Transplant Proc 1993 0.75
1270 Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 1996 0.75
1271 Long-term survival of islet allografts in diabetic rats treated with FK 506. Transplant Proc 1991 0.75
1272 Opportunities and costs of clinical research. Semin Liver Dis 1985 0.75
1273 Liver scans after orthotopic hepatic homotransplantation, biliary obstruction, and devascularization procedures. Surg Forum 1968 0.75
1274 The use of MHC class I or class II "knock out" mice to investigate the role of these antigens in allosensitization. Transplant Proc 1995 0.75
1275 Tolerance to skin and vascularized cardiac allografts using mixed chimerism. Transplant Proc 1992 0.75
1276 Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. Transplant Proc 1989 0.75
1277 Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. Transplant Proc 1996 0.75
1278 FK 506 modulates D-galactosamine-induced hepatitis in rats. Transplant Proc 1991 0.75
1279 Urine plasmin-like substances as an index of kidney allograft rejections. Transplantation 1977 0.75
1280 Outcome after Liver Transplantation for Cystic Fibrosis. Pediatr Pulmonol Suppl 1991 0.75
1281 A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients. Transplant Proc 2002 0.75
1282 Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. Transplant Proc 1991 0.75
1283 Intestinal transplantation at the University of Pittsburgh: six-year experience. Transplant Proc 1997 0.75
1284 Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. Transplant Proc 1992 0.75
1285 Extrinsic reinnervation of the intestine after small bowel autotransplantation in dogs. Transplant Proc 1994 0.75
1286 Protective effects of the lazaroid U74500A and lidoflazine on liver preservation with UW solution. Transpl Int 1993 0.75
1287 Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline. Transplant Proc 1999 0.75
1288 Alopecia as a consequence of tacrolimus therapy. Transplantation 1998 0.75
1289 Cyclosporine Metabolite Profiles in the Blood of Liver Transplant Patients. Transplant Proc 1988 0.75
1290 HLA antigens in primary sclerosing cholangitis. Transplant Proc 1992 0.75
1291 Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. Transplantation 1997 0.75
1292 Basic considerations for the procurement of intestinal grafts. Transplant Proc 1994 0.75
1293 Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats. Transplant Proc 1991 0.75
1294 In vivo and in vitro effect of FK 506 on rat Leydig cell function. Transplant Proc 1991 0.75
1295 Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts. Transplant Proc 1997 0.75
1296 Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation. Transplant Proc 2000 0.75
1297 Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. Transplant Proc 2001 0.75
1298 Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. Transplant Proc 1994 0.75
1299 Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cells. Transplant Proc 1997 0.75
1300 Histopathologic changes of antibody-mediated small bowel graft rejection in blood-transfused recipients. Transplant Proc 1996 0.75
1301 Long-term effect of jejunoileal autotransplantation on motility and transit time in canine small bowel. Transplant Proc 1994 0.75
1302 Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. Transplant Proc 1999 0.75
1303 Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. Transplant Proc 1996 0.75
1304 Intrapancreatic islet transplantation as a potential solution to chronic failure of intraportal islet grafts. Transplant Proc 1993 0.75
1305 Hepatocyte anoxic injury is prevented by high concentration of fructose. Transplant Proc 1992 0.75
1306 Anesthesia experience with living renal transplant donors. Anesth Analg 1971 0.75
1307 Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. Transplant Proc 1995 0.75
1308 The role of Fas/FasL apoptotic pathway in the development of chronic rejection. Transplant Proc 1999 0.75
1309 Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 1992 0.75
1310 Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients. Transplantation 1995 0.75
1311 Cyclosporine and liver regeneration studied by in vivo 31P nuclear magnetic resonance spectroscopy. Dig Dis Sci 1991 0.75
1312 Effects of phytohemagglutinin on humoral antibody response, delayed hypersensitivity, and homograft rejection. Surgery 1970 0.75
1313 Pediatric liver transplantation from neonatal donors. Transpl Int 1992 0.75
1314 Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts. Transplant Proc 1996 0.75
1315 Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc 1997 0.75
1316 Fluorometric study of the viability of rat liver grafts after simple cold storage with UW solution versus Euro-Collins solution. Transplant Proc 1991 0.75
1317 Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection. Transplant Proc 1994 0.75
1318 The reduction of antigenicity of heterologous antilymphocyte serum with acid Taka-protease. Clin Exp Immunol 1972 0.75
1319 Lack of association between HLA antigen DR3 and alpha 1-antitrypsin deficiency in liver transplant recipients. Dig Dis Sci 1993 0.75
1320 Isolation and Partial Purification of Hepatic Stimulatory Substance. Transplant Proc 1988 0.75
1321 Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist. Transplant Proc 1997 0.75
1322 Marked transient alkaline phosphatemia following pediatric liver transplantation. Am J Dis Child 1989 0.75
1323 Effects of peritransplant administration of hematopoietic growth factors on the development of chronic allograft rejection. Transplant Proc 1999 0.75
1324 Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther 1998 0.75
1325 Pretransplant assessment of human liver grafts by plasma lecithin: cholesterol acyltransferase (LCAT) activity in multiple organ donors. Transpl Int 1992 0.75
1326 Liver transplantation in biliary atresia with concomitant hepatoma. S Afr Med J 1972 0.75
1327 Successful islet allotransplantation in diabetic rats immunosuppressed with FK506: a functional and immunological study. Metabolism 1994 0.75
1328 HLA-DR matching effect in orthotopic liver transplantation under FK 506. Transplant Proc 1993 0.75
1329 Preservation of the retrohepatic vena cava during recipient hepatectomy for orthotopic transplantation of the liver. Surg Gynecol Obstet 1989 0.75
1330 Occult purulent pericarditis detected by indium-111 leukocyte imaging. Chest 1984 0.75
1331 The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion. Transplant Proc 1995 0.75
1332 Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. Transplant Proc 1991 0.75
1333 Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. Transplant Proc 1996 0.75
1334 Renal transplantation under cyclophosphamide. Transplant Proc 1972 0.75
1335 Cytokine messenger RNA profiles in hamster-to-rat liver xenografts. Transplant Proc 1993 0.75
1336 Orthotopic liver transplantation for hemochromatosis. Transplant Proc 1991 0.75
1337 Failure of renal homograft protection with RNA pretreatment. Transplantation 1978 0.75
1338 Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. Transplant Proc 1996 0.75
1339 Effect of antiandrogen flutamide on measures of hepatic regeneration in rats. Dig Dis Sci 1989 0.75
1340 Donor-recipient microchimerism and tolerance induction. Transplantation 1996 0.75
1341 Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface. Transplant Proc 1999 0.75
1342 Adult respiratory distress syndrome secondary to end-stage liver disease-successful outcome following liver transplantation. Transplantation 1993 0.75
1343 Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. Transplant Proc 1993 0.75
1344 Segmental hepatic graft. Transplantation 1995 0.75
1345 [Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center]. Helv Chir Acta 1989 0.75
1346 Tacrolimus-based immunosuppression in pediatric renal transplantation. Transplant Proc 1999 0.75
1347 An evaluation of perfusion constituents in liver preservation. Surg Forum 1968 0.75
1348 Specific effect of University of Wisconsin solution on renal hemodynamics and microvasculature in canine kidney preservation. Transplant Proc 1990 0.75
1349 A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. Transplant Proc 1991 0.75
1350 In a small Iowa town. Transplant Proc 1988 0.75
1351 Long-term survival of heart and liver xenografts with splenectomy and FK 506. Transplant Proc 1993 0.75
1352 Results with cyclosporine in renal transplantation in patients who have lost two previous allografts. Surg Gynecol Obstet 1987 0.75
1353 Immunocytes of composite tissue allografts express elevated levels of TGF beta mRNA and protein during chronic rejection. Transplant Proc 1997 0.75
1354 Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 1997 0.75
1355 Intestinal transplantation in 31 adults. Transplant Proc 1996 0.75
1356 Does the presence of a measurable blood alcohol level in a potential organ donor affect the outcome of liver transplantation? Alcohol Clin Exp Res 1991 0.75
1357 Anoxia/reoxygenation injury in hepatocytes is not prevented by calcium channel blockers. Transplant Proc 1992 0.75
1358 Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc 1997 0.75
1359 Pediatric liver transplantation. Part II. Diagnostic imaging in postoperative management. Radiology 1985 0.75
1360 Estrogen and androgen receptors in the liver after orthotopic liver transplantation. Transplant Proc 1989 0.75
1361 Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium. Transplant Proc 1991 0.75
1362 Nonobstructing colonic dilatation and colon perforations following renal transplantation. Arch Surg 1990 0.75
1363 Effect of preoperative thoracic duct drainage on canine kidney transplantation. J Invest Surg 1997 0.75
1364 Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Transplant Proc 1988 0.75
1365 Endothelin-1 receptor blockade and its effect on chronic rejection. Transplant Proc 1999 0.75
1366 Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc 1996 0.75
1367 Plasma lecithin/cholesterol acyltransferase (LCAT) activity in multiple-organ donors: a predictor of allograft viability in clinical liver transplantation. Transplant Proc 1990 0.75
1368 Organ transplantation--then and now. Hosp Physician 1987 0.75
1369 Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc 1997 0.75
1370 Five-year experience with tacrolimus rescue for renal allograft rejection. Transplant Proc 1997 0.75
1371 Chronic immunosuppression, Australia antigenemia, and hepatitis. Transplant Proc 1972 0.75
1372 The clearance of cyclosporine by hemodialysis. J Clin Pharmacol 1985 0.75
1373 Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc 1993 0.75
1374 Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation. Transplant Proc 1994 0.75
1375 Peripheral blood T lymphocytes found in renal allograft recipients treated with cyclosporine. Transplantation 1983 0.75
1376 Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. J Heart Lung Transplant 1997 0.75
1377 Operative implications of preduodenal portal vein. Surgery 1979 0.75
1378 Is rejection a diffuse or localized process in small-bowel transplantation? Surg Endosc 1994 0.75
1379 Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. Transplant Proc 1995 0.75
1380 Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc 2001 0.75
1381 In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 1991 0.75
1382 Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients. Transplant Proc 1995 0.75
1383 Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. Transplant Proc 1998 0.75
1384 FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice. Transplant Proc 1991 0.75
1385 Pancreas transplantation. J Am Coll Surg 1998 0.75
1386 Sodium lactobionate sucrose solution for canine liver and kidney preservation. Transplant Proc 1993 0.75
1387 Circadian rhythm of hepatic cytosolic and nuclear estrogen receptors. Chronobiol Int 1986 0.75
1388 Radioiodinated rose bengal kinetics in extrahepatic biliary obstruction and hepatic homograft rejection in the dog. Surg Forum 1972 0.75
1389 Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation. Transplant Proc 1994 0.75
1390 Effect of partial portal vein ligation on hepatic regeneration. J Invest Surg 1988 0.75
1391 Phosphorus 31-nuclear magnetic resonance spectroscopy of rat liver during simple storage or continuous hypothermic perfusion. J Lab Clin Med 1992 0.75
1392 Neuroradiologic aspects of pediatric orthotopic liver transplantation. AJNR Am J Neuroradiol 1988 0.75
1393 The use of FK 506 in new-onset type I diabetes in man. Transplant Proc 1991 0.75
1394 Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model. Transplantation 1996 0.75
1395 State of immunosuppressive agents in organ transplantation. Transplant Proc 1992 0.75
1396 Pulmonary surgery in immunosuppressed patients. J Thorac Cardiovasc Surg 1970 0.75
1397 Visual improvement after long-term success of pancreatic transplantation. Am J Ophthalmol 1990 0.75
1398 Rejection and hepatitis in liver transplants. Transplantation 1994 0.75
1399 Detection of intrahepatic human islets following combined liver-islet allotransplantation. Pancreas 1992 0.75
1400 The antigenicity of serum proteins and their role in xenograft rejection. Transplant Proc 1996 0.75
1401 Chimerism, graft-vs-host disease, rejection, and their association with reciprocal donor-host immune reactions after cell, organ, and composite tissue transplantation. Transplant Proc 1997 0.75
1402 Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transplant Proc 1993 0.75
1403 Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats. Cell Transplant 1994 0.75
1404 Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients. Transplant Proc 2007 0.75
1405 Expression of blood group antigen (A, B, H, Le(a), Le(b)) on liver allografts. Transplant Proc 1992 0.75
1406 Pancreas procurement from multiorgan donors for islet trasplantation. Diabetes Nutr Metab 1992 0.75
1407 Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion. Jpn J Surg 1974 0.75
1408 Functional evaluation of isolated islets from baboon pancreata. Transplant Proc 1995 0.75
1409 The ripple effect of liver transplantation. Transplant Proc 1980 0.75
1410 Portal vein thromboembolism of liver allografts from splenectomized donors. Transplantation 1989 0.75
1411 Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc 2002 0.75
1412 Future aspects of renal transplantation. World J Urol 1988 0.75
1413 Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplant Proc 1982 0.75
1414 Lazaroid U-74500A for warm ischemia and reperfusion injury of the canine small intestine. J Am Coll Surg 1997 0.75
1415 Repair of posterior aortic anastomotic leaks. Surg Gynecol Obstet 1974 0.75
1416 [Treatment of type II familial hyperlipemia by portacaval shunt]. Nouv Presse Med 1977 0.75
1417 Liver transplantation in man. Postgrad Med 1973 0.75
1418 Intestinal transplantation: current status and latest developments. Surg Technol Int 1999 0.75
1419 The effect of portacaval shunt on hepatic lipoprotein metabolism in familial hypercholesterolemia. J Surg Res 1985 0.75
1420 Backtable angioscopy to evaluate the renal artery. Transplantation 1992 0.75
1421 Renal homotransplantation: 20 to 36 months later. Mil Med 1966 0.75
1422 Insulin requirements after liver transplantation and FK-506 immunosuppression. Transplantation 1993 0.75
1423 Neonatal bone fragments for the induction of xenograft acceptance: transplantation of xenogeneic hematopoietic stem cells and species-specific microenvironment for hematopoiesis. Transplant Proc 1997 0.75
1424 The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted. Transplant Proc 1995 0.75
1425 Hormones, growth factors and oncogenes in the evaluation of risk for hepatocellular carcinomas. Eur J Cancer Prev 1992 0.75
1426 Transplantation of the liver. Prog Liver Dis 1970 0.75
1427 [Abdominal appraoch to the supra-hepatic vena cava]. Chirurgie 1974 0.75
1428 Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression. Surg Technol Int 1996 0.75
1429 The status of liver transplantation. Bull Am Coll Surg 1985 0.75
1430 [Social rehabilitation after renal transplantation]. Rev Med Suisse Romande 1973 0.75
1431 Letter: Renal transplantation in children. Surgery 1975 0.75
1432 Cytomegalovirus gastroenteritis after liver transplantation. J Pediatr 1988 0.75
1433 Liver transplantation. Bull Soc Int Chir 1967 0.75
1434 [Clinical experience with FK 506]. Presse Med 1991 0.75
1435 Mechanisms of protection from humoral rejection by a xenografted liver. Transplant Proc 1995 0.75
1436 Amelioration of liver damage induced by ischemia and reperfusion with FR167653; a newly synthesized cytokine suppressive antiinflammatory drug. Transplant Proc 1998 0.75
1437 Simplified biopsy of the liver in dogs. Surg Gynecol Obstet 1977 0.75
1438 Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. Transplant Proc 2000 0.75
1439 FK 506: an effective immunosuppressant for islet xenotransplantation. Transplant Proc 1992 0.75
1440 Can adenine nucleotides predict primary nonfunction of the human liver homograft? Transplant Proc 1993 0.75
1441 Hepatic transplantation in Wilson disease. Birth Defects Orig Artic Ser 1973 0.75
1442 Computer-guided concentration-controlled trials in autoimmune disorders. Ther Drug Monit 1993 0.75
1443 The use of tacrolimus in renal transplantation. World J Urol 1996 0.75
1444 Renal homotransplantation: 21 to 37 months later. Urol Int 1966 0.75
1445 The effect of donor age on the outcome of islets isolated from human pancreata. Transplant Proc 1995 0.75
1446 Renal homotransplantation. I. Curr Probl Surg 1974 0.75
1447 Introduction of Felix Rapaport for 1998 Medawar Prize. Transplant Proc 1999 0.75
1448 The effect of preservation fluid on the blood flow of pediatric liver allografts. Transplantation 1989 0.75
1449 Postmortem organ procurement for transplantation. Ann Intern Med 1983 0.75
1450 [Progress and prospects in renal and hepatic transplantation]. Ann Chir 1966 0.75
1451 Liver transplantation today. Postgrad Med 1987 0.75
1452 [Neuropathological findings in liver transplantation. Study of 29 cases]. Med Clin (Barc) 1985 0.75
1453 Immunological factors influencing liver graft survival. Gastroenterol Clin North Am 1988 0.75
1454 Spleen mixed leukocyte chimerism and induction of tolerance in rat renal allograft recipients conditioned with donor-specific blood transfusions and cyclosporine. Transplant Proc 1995 0.75
1455 Antithrombin III during liver transplantation. Transplant Proc 1989 0.75
1456 Successful treatment of angina pectoris with liver transplantation and bilateral internal mammary bypass graft surgery in familial hypercholesterolemia. Am Heart J 1988 0.75
1457 Technics of histocompatibility testing. N Engl J Med 1970 0.75
1458 FK 506 interaction with danazol. Lancet 1993 0.75
1459 Venovenous bypass using inferior mesenteric vein for portal decompression during orthotopic hepatic transplantation. J Am Coll Surg 1995 0.75
1460 Relationship between the dose and whole blood level of cyclosporine after liver and kidney transplantation. J Clin Lab Immunol 1992 0.75
1461 Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506. Transplant Proc 1994 0.75
1462 Percutaneous approach for human islet transplantation. Transplant Proc 1992 0.75
1463 [Prognosis of hepatic transplantation as a function of biological, immunological and functional preoperative findings]. Acta Gastroenterol Belg 1988 0.75
1464 Transplantation. Abstract from 1970. J Am Coll Surg 1998 0.75
1465 Transplantation. Surg Gynecol Obstet 1970 0.75
1466 Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. Transplant Proc 1994 0.75
1467 Hemodynamic changes in clinical orthotopic liver transplantation. Surg Forum 1971 0.75
1468 An interesting intraoperative decision. Arch Surg 1999 0.75
1469 Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Clin Transplant 1995 0.75
1470 Intrahepatic bile duct strictures in a liver allograft recipient mimicking recurrent primary sclerosing cholangitis. Follow-up of a case report. Transpl Int 1991 0.75
1471 Changes of portal venous flow velocity after liver transplantation and its causes. Transplant Proc 1994 0.75
1472 A transplanter's credo. Transplant Proc 1991 0.75
1473 Portal vein thrombosis and protal diversion. J Pediatr 1983 0.75
1474 Donors for liver transplantation. Pediatrics 1983 0.75
1475 A simplified method for growing dendritic cells from rat bone marrow. Adv Exp Med Biol 1995 0.75
1476 Replacement of donor cells after liver transplantation. Transplantation 1987 0.75
1477 Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival. Transplant Proc 1994 0.75
1478 Clinical experience with horse antihuman ALG. Transplant Proc 1972 0.75
1479 Reversal of hyperglobulinemia after orthotopic liver transplantation. N Engl J Med 1989 0.75
1480 Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. Transplant Proc 1991 0.75
1481 The true one-handed tie. Surg Gynecol Obstet 1982 0.75
1482 Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). Xenobiotica 2009 0.75
1483 Initial studies with FK506 in renal transplantation. Cleve Clin J Med 1991 0.75
1484 Liver transplantation in Australia. Med J Aust 1987 0.75
1485 Liver transplantation. Z Gastroenterol 1978 0.75
1486 A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc 1999 0.75